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 Abstract 
Engineering Microenvironmental Cues for Guiding Stem Cell Fate 
Ji Sun Park 
 
Injury, aging, and congenital disabilities of the muscular and neural systems impose a 
significant burden on patients and their families. Due to the tissue’s limited regenerative 
capacity, effective treatment interventions for restoring progressive damage is still lacking. 
Cell replacement therapy is primarily limited by the restricted supply of viable donor cells and 
variable graft survival. For addressing these limitations, we propose new strategies to obtain a 
target cell of interest from an autologous cell source. Herein, we engineer cell fate decisions 
by 1) harnessing host microenvironment and the CRISPR/dCas9-mediated transcriptional 
activation system to promote myogenesis of human endothelial progenitor cells (EPCs); and 
2) employing substrate-mediated biophysical cues with soluble factors (biochemical cues) to 
drive cell commitment to neuronal lineages.  
For the first strategy, we hypothesized that therapeutic cells could be obtained in situ 
by employing the CRISPR/dCas9 system to engineer cell fate in the host tissue. Using this 
system, we transactivated MYOD1, a master regulator for myogenesis, to directly reprogram 
primary EPCs to skeletal myoblasts (SkMs). EPCs were chosen as a cell source for their easy 
accessibility, high proliferation, and potential contribution to regenerate vasculature and 
musculature tissue. The early myogenic commitment of EPCs was confirmed in vitro by 
MYOD1 expression, which yielded a 230-fold higher induction than the original EPCs. These 
cells were then transplanted for assessing their therapeutic efficacy in myotoxin-induced 
muscle injury model in immunodeficient mice. A one-month post-injury study resulted in the 
integration of induced SkMs to the injured host tissue, promotion of neoangiogenesis, and 
reduction in fibrotic scar formation. These findings indicate that CRISPR/Cas9-mediated target 
gene activation can be achieved in situ to accelerate muscle regeneration after myotoxin-
induced damage.  
For the second strategy, we utilized both soluble and insoluble factors to convert the 
cell fate of neural stem/progenitor and somatic cells to various neuronal lineages, including 
motor neurons (MNs) and dopaminergic (DA) neurons. For soluble factors, cells were exposed 
to various biochemical factors, inspired by the neuronal niche environs during the natural 
developmental process. For insoluble factors, the conductive graphene substrate was used to 
support the endogenous electrical signal between neurons for enhancing the neuronal 
phenotypes and their functionality. We postulated that exposing the cells to these collective 
stimuli in vitro can alter their intrinsic signaling pathway to tailor their fate to neuronal 
lineages. To test the hypothesis, neural stem/progenitor and somatic cells were cultured on 
various substrates with or without electroactive graphene and aligned patterns. After two weeks 
to one month of cell fate induction in the chemically defined conditions, our results implied 
that cell adhesion, survival, neurite outgrowth, and maturation were facilitated on the 
electroactive substrates with aligned patterns compared to the control platforms.  
Taken together, our results in this dissertation demonstrate the feasibility of tailoring 
the donor cell fates within or across the germ layers. We achieved this by employing a 
transcriptional gene activation system and tunable microenvironmental cues elicited by soluble 
(chemical and growth factors) and insoluble (physical cues from the substrate) factors. 
Utilizing such strategies hold great promise for elucidating the optimal conditions to guide cell 
fate to target lineages. This work provides a rational basis for establishing a robust protocol 
and an in vitro culture platform to module cell fate decisions that could help realize the 
autologous cell-based therapy for muscular and neurodegenerative diseases. 
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Chapter 1. Introduction: motivation and objectives 
 
 
1.1. Clinical Significance: Muscular and Neuronal Diseases  
 
With the increase in life expectancy and advances in medical prognosis, patients with muscular 
and neuronal diseases (MNDs) are projected to elevate across the world. It is more devastating 
as a wide range of progressive MNDs currently lack viable treatment options and only partially 
relies on the rehabilitation and palliative treatment methods to alleviate the symptoms, instead 
of restoring the loss of tissues. This stems from an inability to proliferate and replace the 
damaged tissues and not being able to obtain self-renewing therapeutic cells for replacing 
damaged tissues. Therefore, lacking effective therapeutic modalities still imposes a high 
societal and economic burden on patients with MNDs.  
For circumventing these limitations, numerous groups have investigated on how 
cellular microenvironments can be modulated for stem cell development, activation, and 
differentiation either by cell-to-surface or cell-to-cell interactions. Among the various 
strategies, three of them are employed herein to modulate programmed cell determination: 1) 
3D microenvironmental cues, 2) cocktails of soluble factors, and 3) insoluble biomaterial-
mediated topographical cues. 
For achieving cell fate transition, we targeted the excitable cells, which transmits action 
potential signals from the central nervous system (CNS) to skeletal myofibers at the 
neuromuscular junction (NMJ); MN’s axon transmits chemical signals across a synapse from 
the spinal cord to skeletal muscle for facilitating voluntary movements (Figure 1). For both 
















neurogenesis. They are closely connected at the neuromuscular junction to process the 
electrochemical signals from the CNS to the contractile machinery for generating voluntary 
movements. Any impairment or interruption from the injury or disease between these systems 
would lead to compromised muscle/neural functions, paralysis, or suffer in pain for the rest of 
one’s life. This is due to the limited regeneration capability of the mitotically quiescent mature 
neuronal and muscular cells.  
 
1.1.1.  Muscular injury/disease  
Musculoskeletal diseases from aging, trauma, injury, and genetic mutations induce muscle 
weakness and impaired functions. Although it is a significant challenge our society and it only 
expects to escalate as the life expectancy is projected to increase, no effective treatment 
modalities are available.  
 
1.1.2.  Neurodegenerative disease 
For the scope of this study, we plan to focus only on the two major neurodegenerative diseases, 
which are one of the most debilitating, costly, prevalent, and incurable diseases: Lou Gehrig’s 
Disease/Amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).   
ALS, named after a baseball player Mr. Lou Gehrig, is a fatal neurodegenerative disease 
caused by the progressive death of MNs, regulating the voluntary movements. It affects about 
30,000 patients every year worldwide and the average life expectancy from two to five years.  
PD is the second most common neurodegenerative disorder of the central nervous 
system (CNS) in the U.S. with symptoms that exacerbate as the disease advances. It is known 
to be caused by the loss of midbrain dopaminergic (mDA) neurons, and its impaired motor 
symptoms are characterized by muscle rigidity, tremor, bradykinesia, and poor balance in 
walking. Currently, it is affecting 1 million patients in the U.S. per year, with a total of 10 
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million patients in the world. The indirect healthcare costs add up to 25 billion per person in a 
year. The progressive degeneration of mDA is one of the significant pathological causes in PD. 
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1.2. Limitations of the Current Therapeutic Modalities 
 
Current technology diagnoses ALS about 9-12 months on average to begin noticing the 
symptoms, while for PD, patients will be diagnosed only after losing 40-70 % of DA neurons 
during the progression of the disease. The more discouraging fact is that during the delay in 
diagnosis, patients’ condition would progressively get worse over time. Moreover, available 
approved modalities only mildly relieve the symptoms and, but wouldn’t ultimately restore 
the voluntary muscle function. For instance, ALS patient given with the first approved 
Riluzole prevents the further loss of MNs by regulating the release of glutamate, but cannot 
restore the progression of the disease (Petrov, Mansfield, Moussy, & Hermine, 2017). 
 For both MNDs, fetal grafts have been used as an attempt to restore the disease 
symptoms. However, due to the lack of viable supply donor cells, associated ethical issues, 
and high immune response, transplanting grafts lead to failure.  
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1.3. Cell-based Therapy as an Alternative Approach 
 
Being highly proliferative and having immunomodulation response, myriads of stem cells are 
being tested to circumvent the ethical issues regarding the usage of fetal grafts from conceived 
embryos. There are currently 24 registered clinical trials for ALS treatment to transplant 
different cell sources, intravenously, or intramuscularly (i.m.). For cell sources, human spinal 
cord-derived neural stem/progenitor cells (NSCs/NPCs), Peripheral blood 
mononuclear cells (PBMC), MSCs secreting neurotrophic factors, astrocytes derived from 
ESCs, and adipose tissue-derived stem cells have been registered (“NIH Clinical Trials1,” 
2019). 
Similarly, 12 registered clinical trials for the PD treatment practices the usage of MSCs, 
NSCs, NSC-derived neurons, and NPCs into the intracerebral cortex (“NIH Clinical Trials2,” 
2019). Various cell sources have been explored for this approach: 1) grafting donated fetal 
tissues; 2) transplanting human embryonic stem cell (ESC)- or iPSC-derived multipotent 
stem/progenitor cells, including PBMC, mesenchymal stem cells (MSCs), NSCs and NPCs; 
and 3) implanting autologous cells derived from patients. Especially, stem/progenitor cells 
derived from mesoderm PBMC, mesenchymal stem cells (MSCs), and adipose-derived stem 
cells (ADSCs) have been extensively used as a cell source for their highly proliferative capacity 
(with well-defined proliferation media compositions and characterization markers), easy 
accessibility, immunomodulatory behaviors, and paracrine effect for secreting tropical 
effectors.   
Cell-based therapy has galvanized its recognition as an alternative modality against 
treating muscular and neural diseases (MNDs) for cells being identified as independent 
dynamic machinery, adapting and responding to their surrounding environs. Attributing to 
these features of cells, researchers hypothesized that implanted cells could expand in a host 
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environment to migrate, proliferate, and mitigate pathophysical responses in congenital 
abnormalities, diseased or injured tissues by reducing inflammation and secreting tropical 
effectors. In this aspect, autologous cell replacement therapy has become an ideal therapeutic 
intervention for the regenerative cell-based therapies with no associated ethical concerns and 
risks of teratoma formation using pluripotent stem cells (PSCs).  
Replacing stem cells or terminally differentiated cells have limited therapeutic 
potentials attributed to the limited ability to obtain sizable amounts of implantable cells at these 
target sites. To address this limitation of obtaining therapeutically relevant amounts of cells for 
autologous cell therapy. Our strategies involve modulating the microenvironmental cues to 
regulate cell fate decisions (differentiation, reprogramming, and transdifferentiation) by 1) 
directly converting the cell lineage through targeted transcriptional activation, or 2) mimicking 
the target cell niche to provide tailored stimuli to cells.  
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1.4. Objective and Specific Aims 
 
The objective of my thesis is to obtain therapeutic cells for regenerative medicine in cell-based 
therapy and tissue engineering applications by developing a robust technique and an in vitro 
culture platform for altering the transcriptional fate of stem/progenitor and somatic cells. We 
expect that developing these lineage-specific target cells can lead to realizing the autologous 
cell-based therapy against MNDs, which currently lacks viable treatment options. We 
hypothesize that employing various environmental cues inspired by the cell’s niche would 
instruct and regulate cell fate outcomes for the neuronal and muscular systems. To validate our 
hypothesis, we harnessed a targeted transcriptional activation system and biomimetic 
microenvironmental cues (soluble and insoluble factors) for promoting transdifferentiation and 
differentiation in the muscular and neuronal systems, respectively. The microenvironmental 
cues in this study encompass orchestrated signals from the in vivo microenvironment, 
biochemical cues from the supplemented media, and bioelectrical and topographical cues from 
the substrate. Utilizing these factors, herein, we attempt to mitigate the current processes of 
expensive, inefficient, and cumbersome in vitro expansions of target cells by providing their 
niche-like environments. Figure 2 illustrates the common theme of the thesis and specific aims 












Figure 2. The summarized illustration of inter-lineage cell fate conversions aims to 
achieve for the thesis. Aim 1 demonstrates the promoted myogenic potential of mesodermal-
derived multipotent endothelial progenitor cells (EPC) to SkM, and Aim 2 evaluates to enhance 
the directed differentiation of iPSC-derived NSC/NPC to specific neuronal lineages and direct 




1.4.1.  Specific Aim 1: Harnessing the in vivo host microenvironment 
for the in situ reprogramming of EPCs using the CRISPR/dCas9 
system 
i. Establishing reprogrammable EPCs in vitro using the CRISPR/dCas9 system 
ii. Evaluating the engraftment and maturation of the reprogrammed EPCs in vivo  
iii. Assessing the contribution of the non-reprogrammed cells to neoangiogenesis   
 
Hypothesis: Microenvironmental cues from the in vivo host muscle promotes the myogenic 
potential of transduced EPCs by activation of endogenous MYOD1 using the CRISPR/dCas9 
system 
 
In specific aim 1, we employed the clustered regularly interspaced short palindromic repeats 
(CRISPR)‐associated protein 9 (CRISPR/Cas9) gene-editing system to genetically modulate 
cell commitment. For inducing myogenesis of the primary human endothelial progenitor cells 
(EPCs), deactivated dCas9 was used to transactivate the target endogenous gene instead of 
causing a double-strand break. Unlike conventional forced ectopic expression of transcription 
factors, the CRISPR/dCas9 activation system allows economic and precise control of the 
transcriptional network with potential for multiplexing.  
Utilizing this gene-editing tool, we first established a protocol to obtain 
reprogrammable EPCs by transducing them with doxycycline (dox)-inducible lentiviruses for 
delivering CRISPR/dCas9, gRNAs, and m2rtTA. Although optimized gRNA cocktails were 
used and transduced EPCs were further sorted to select the cells expressing MYOD1, our target 
gene, resulting transduced EPCs had immature skeletal myoblasts in vitro even after the long-
term induction. Hence, requiring additional biochemical cues that mimics the niche-like 
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microenvironment to further mature to functional skeletal muscle cells.  
Based on the limited capacity of cell fate conversion in vitro, we hypothesized that the 
in vivo microenvironment would facilitate the cell commitment decisions in situ. To increase 
the survivability, integration, and reprogramming efficiency of transplanted cells in vivo, a 
myotoxin-induced muscle injury model of an immunodeficient mammalian model was selected 
as a host.  
Lastly, as the direct lineage conversion process cannot be 100 % efficient, we assessed 
the function of non-reprogrammed EPCs to the local neoangiogenesis for ameliorating the 
injury site.  
 
 
1.4.2. Specific Aim 2: Employing substrate-mediated bioelectrical and 
topographical cues to enhance the cell fate-specific to neuronal 
lineages  
i. Promoting the directed differentiation of human NSCs to neuronal lineages 
ii. Enhancing the small molecule-mediated direct reprogramming of human 
fibroblasts to induced neurons   
 
Hypothesis: Electroactive substrates offering the topographical and biochemical cues 
enhances the cell fate decisions to neuronal lineages along with the soluble cues provided by 
the chemically-defined conditions.  
 
For the specific aim 2, it was hypothesized that we could instruct neural stem/progenitor cells 
(NS/PCs) to mature and achieve functional neuronal lineages as well as guide fibroblasts to 
transdifferentiate into induced neurons (iNs) using cocktails of multiple soluble factors 
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synergistically combined with substrate-mediated bioelectrical and topographical cues. This 
strategy eliminates the usage of transcription factors and viruses to deliver them, allowing for 
a simple, rapid, cost-effective, and safe method to epigenetically convert cell commitments. 
Moreover, the usage of chemical cocktails renders a more conducive environment for 
transformation or maturation to neuronal lineages by remodeling chromatin structures. For the 
substrate, highly conductive graphene: poly-lactide-co-glycolide (PLG) copolymer composite 
was used to examine the effect of an electroactive substrate on enhancing the adaptation of the 
neuronal lineage possibly through promoting their cell-to-cell signaling. Furthermore, an 
anisotropic patterned substrate was assessed for instructing cell alignment, an additional 
influence on cell phenotype change. For both MN differentiation and neurogenesis of 
fibroblasts, patterned graphene substrate had the most efficient conversion of cells with higher 
attachment compared with the control. These findings may advance our understanding of how 
multifunctional-engineered biomaterials can play a significant role in developing optimal 
differentiation and transdifferentiation platforms by mimicking the intricacy of natural tissue 
environments.  
Collectively, these findings reveal that specific cell lineage determinations can be 
tailored by modulating intricate microenvironmental cues, directly, by activating the lineage-
specific master regulator gene or indirectly, by exposing cells to chemical, bioelectrical, and 
topographical cues from their culture conditions (media and substrates). With these culture 
systems, more autologous target cells of interest may be obtained with less time and effort. 
These systems may, in turn, serve as emerging cell-based therapies for MNDs or be 




1.5. Chapter Overview  
 
The common topic throughout this dissertation is to harness the soluble and insoluble 
microenvironmental cues (e.g., substrate-mediated biophysical factors and soluble biochemical 
factors) with a goal to obtain autologous therapeutic cells for in vivo applications, and to 
establish an in vitro culturing protocol/platform to realize personalized regenerative medicine 
against neuronal and muscular injuries/diseases.  
Especially, Chapter 2. Background information of the dissertation reviews the relevant 
background information to help understand the research topics. Chapter 3. In situ 
reprogramming of EPCs by transactivation of endogenous MYOD1 using the CRISPR/dCas9 
system examines the therapeutic efficacy of utilizing CRISPR/dCas9-mediated targeted 
transcription for cell fate conversion of human EPCs to induced SkMs (iSkMs) in the niche-
like in vivo system. While, Chapter 4. Enhancing the neural cell fate commitment by 
deploying biochemical cues and substrate-mediated electrophysical cues attempts to establish 
an electroactive in vitro culture platform to enhance the cell fate conversion to subtype neuronal 
cell commitment from various cell sources exposed to defined biochemical and physical cues. 
Collectively, Chapter 5: Summarized conclusion and future perspectives highlights the 








Chapter 2. Background information 
 
 
2.1. Cell Fate Portrayed from the Waddington’s Landscape 
 
Scientists have recently estimated the total number of cells to be 37 trillion cells in our body. 
Although based on age and sex, the number would vary, it is incredible how these cells 
concomitantly differentiate into more than 200 types of lineages in our body throughout our 
life to function uniquely at their niche. It is crucial that these committed cells grow and mature 
as designed. Otherwise, it results in devasting disorders or pathological conditions with the 
impaired or failed function of the tissue. Therefore, understanding the cell niche during cell 
development, regeneration, and healthy conditions offer how these environmental signals can 
engineer cell fate.  
 The phenomena of the cell-fate specification have been well conceptualized by Conrad 
Waddington for the first time as a Waddington’s landscape, shown in Figure 3. He portrayed 
the normal development, differentiation, of a pluripotent stem cell as a ball rolling down from 
a slanted hilltop, which leads to varying landscapes of valleys to the end destination. During 
the ball dropping process, it can choose different pathways along the way to its final destination 
(terminally differentiated state), but its pathway could be different. Top to bottom illustrates 
the gradient of high to low pluripotency state of the cell (the ball). The addition of a robust 
fate-determining factor, such as lineage-instructive transcriptional factor, attracts the ball to the 
particular lineage. After the ball drops to such a stable location, it will not move elsewhere due 
to “epigenetic barriers” around it. This stable state represents an ‘attractor state,’ which is 












Figure 3. Illustration of the Waddington’s Landscape on the 1) normal process of aging, 2) 
reprogramming, and the 3) direct reprogramming. Top green cell indicates the pluripotent stage 
of the cell, while blue and yellow indicate the differentiated cell states. Adapted from 




to change by external factors. This phenomenon was first proved in 2006 by Yamanaka that 
the addition of four fate-changing transcription factors, known as OSKM (Oct-4, Sox2, Klf-4, 
and c-Myc), would revert the ball to the top of the hill, thereby conferring pluripotency to the 
somatic cells—reversing the aging. Their finding was evolutionary, and these factors were 
named as Yamanaka factors. Soon in 2010, these epigenetic barriers were proven to be 
overcome across the germ layer by a mixture of powerful lineage-instructive transcriptional 
factors. This was first demonstrated in fibroblast-to-myoblast conversion by overexpression 
Myod1(Davis, Weintraub, & Lassar, 1987). Feasibility to repurpose the cell fate via direct 
lineage conversion offered scientists to avoid the iPSC generation to obtain their target cell of 
interest, shortening the processing time and expenses immensely. Since then, various 
transcription factor cocktails (Ambasudhan et al., 2011; Caiazzo et al., 2011; Cao et al., 2016; 
Han et al., 2012; Vierbuchen et al., 2010) were identified to drive the lineage-specific direct 
reprogramming. Furthermore, in conjunction with these fate-changing transcription factors, 
researchers found the chemically-defined conditions which could further favor the lineage 
specification to the target fate upon adding soluble factors, such as epigenetic modulators 
(Ebrahimi, 2015; Zhang, Li, Laurent, & Ding, 2012).  
In the later chapters, two strategies will be harnessed for guiding the cell fate of 
multipotent stem/progenitor cells and somatic cells by changing: 1) the intrinsic transcriptional 
network mediated by the CRISPR/Cas9; and by 2) exposing cells to the substrate-mediated 
biophysical cues along with the biochemical cues to epigenetically modulate the gene 




2.2. CRISPR/dCas9 System: The Ultimate Gene Editing 
Toolbox 
 
For our first strategy, the clustered regularly interspaced short palindromic repeat 
(CRISPR)/CRISPR-associated Cas9 nucleases (CRISPR/Cas9) platform was utilized for 
genetically modulating the cell fate. Initially, this system was discovered from the defense 
system of bacteria and archaea. This adaptive immune system relies on the sequence-specific 
recognition of the single-stranded RNAs to inactivate the complementary sequence found in 
the invading foreign genetic elements (viral or plasmid DNA), functionally silencing them by 
inducing double-strand breaks. The sequence information of the foreign invaders gets stored 
as pre-crRNA (pre-CRISPR RNA) by prokaryotes in the CRISPR loci when the phages attack 
the foreign sequence. Later, a mature version of this sequence information is used to target the 
genome loci for complementary base pairing, which leads to cleavage and disruption of the 
target gene expression. Transactivating crRNA (tracrRNA) is also transcribed by CRISPR loci, 
which gets hybridized to crRNA, transcribed by RNase polymerase III. The crRNA-tracrRNA 
dual-RNA guided system has been engineered into a single guide RNA (sgRNA) for sequence-
specific Cas9-mediated gene editing (Jinek et al., 2012). Throughout our project, sgRNA will 
be referred to as gRNA.   
Among many Cas9 variants, in our study, bacterial type II CRISPR/Cas9 system from 
Streptococcus pyogenes (SpCas9) was engineered to inactivate the catalytical nucleases by 
two-point mutations at D10A and H840A (Qi et al., 2013). The new version of catalytically-
deficient/dead form of dCas9 is widely used for regulating gene expression, neither replacing 
the DNA sequence nor causing insertional mutagenesis. For our approach, as shown in Figure 
4, dCas9 is further engineered by dual tethering VP64 activation domains at both N’- and C’-
terminus of dCas9. VP64 activation domain is composed of four tandem repeats of herpes   
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Figure 4. Components of CRISPR/dCas9 system with BFP as a reporter gene, including: 1) 
the target genomic DNA (gDNA), 2) deactivated Cas9 protein tethered with two VP64 
activator domains and 3) chimeric gRNA which guides the dCas9 protein to the target DNA 













simplex viral protein 16 (VP16). VP64 allows transactivation of the endogenous target once 
another protein domain can bind near the target’s promoter. The designed gRNAs, which gets 
recruited to the target gene loci, shares the sequence information as 5’ end -N20-3’end where 
‘N20’ refers to any base sequence in 20 nucleotide (nt) length. This sequence should be 
complementary to the target sequence, immediately followed by ‘NGG,’ known as the 
protospacer-adjacent motif (PAM). PAM sequence allows Cas9 binding to excise 3-4 nt 
upstream of PAM. This moderate qualification for targeting any organism confers efficient and 
simple epigenome editing.  
  
 20 
2.3. Microenvironmental Effects on Cell Fate 
Determination 
 
Engineering the microenvironmental signals exposed to cells can affect cell behavior and 
phenotypes. Cells react to these cues by their cytoskeletal machinery, including intermediate 
filaments and actin stress fibers. There are the interconnected filaments that link the cell 
membrane and nucleus from distance to allow efficient and rapid force propagation when cells 
receive biophysical cues from their microenvironments. Upon transducing concerted signal to 
nucleus, the gene expression profiles can be altered by chromatin and nuclear lamina (lamins 
A, B, and C) remodeling, or by the recruitment of epigenetic modulators, which can permit the 
delivery of transcription factors to the nucleus (Crowder et al., 2016; Wang et al., 2009). It is 
becoming more apparent that the forces—transmitted from the mechanical signaling between 
the cytoskeleton and the extracellular matrix/substrate—exerted on the nucleus may contribute 
to the changes in cell shape, growth, and development (Wang et al., 2009; Iskratsch et al. 2014; 
Missirlis, 2016).  
For our second strategy, we focus on engineering the microenvironmental stimuli (as shown in 
Figure 5, inspired by the cell’s niche environment as an indirect method of providing a milieu 
of lineage-specific biochemical factors and physical cues. Schofield first postulated the concept 
of niche as a site that stem cells reside and contribute to the maintenance and self-renewal of 
neighboring stem cells (Schofield, 1978). Cells are exposed and influenced by various internal 
and external stimuli, thereby restoring cellular homeostasis or adapting to an altered entity by 
changing their morphology and gene expressions (Milisav, 2011). For example, metaplasia is 
a natural adaptive response in the intestine where reversible transformation occurs from an 
undifferentiated stem/progenitor cell type to another tissue-specific stem/progenitor cells, 
absent from that same tissue. This cellular adaptation response is triggered by abnormal 
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microenvironmental stimuli, including the change in pH and hormone levels, or an attack from 
microorganisms (Slack, 2007) as a defense mechanism of cells to produce a repertoire of that 
transformed tissue.  
 
2.3.1. Soluble factors: growth factors and epigenetic modulators 
Utilizing a soluble factor approach for modulating epigenetic signatures of cells offers a safe, 
rapid, and cost-effective strategy that may allow the full realization of generating therapeutic 
cells. The clinical translation of conventional transgenic approaches has been hampered due to 
low efficiency and the risk of viral vectors integrating to the host genome. Therefore, as an 
alternative approach, small molecule-based lineage conversion would be advantageous as it is 
non-immunogenic, stable, rapid, cell-permeable, and easy to standardize. Moreover, it allows 
dose-dependent fine-tuning by modulating the concentration and length of exposure to cells 
(Ye et al., 2016). Because of these advantages, such a strategy could potentially be translated 
into therapeutic applications (Yu et al., 2014). Chemical cocktails can also either activate or 
inhibit key developmental signaling cascades for global gene alterations, which can be tailored 
to yield a more permissive microenvironment for cells to specify cell fate (Downing et al., 
2013).For example, valproic acid is used to induce histone acetylation and reduce epigenetic 
memory of the donor cell, possibly by activating silenced regulatory gene networks necessary 
for lineage reprogramming (Kim et al., 2010; Vierbuchen & Wernig, 2012). Epigenetic 
modulators have been shown to enhance the reprogramming efficiency and include 
transforming growth factor-β inhibitors and Rho-associated kinase inhibitors, which facilitate 









Figure 5. Summarized microenvironmental cues employed in this thesis topic for guiding 
the cell fate in skeletomuscular and neuronal systems: 1) In vivo or 3D cues mimicking the 
niche-environment of the target cell type; 2) substrate-mediated bioelectrical/physical cues 
including the topography and ECM compositions; and 3) biochemical cues activated by the 





2.3.2. Substrate-medicated insoluble factors 
Along with the soluble factors, engineered biomaterials can exert multiple stimuli on cells, 
based on the substrate features (roughness, topography, and chemical compositions). 
Collective signals from the substrate affect cell’s mechanotransduction, epigenetic 
modifications, and MET by their physical network with nucleus and chromatin structure, which 
finally influence reprogramming by the post-transcriptional (epigenetic) processes (Sia, Yu, 
Srivastava, & Li, 2016). Moreover, in vivo, cells continuously adapt to dynamic 
microenvironments, including topographical features from neighboring cells, their secreted 
extracellular matrix (ECM) proteins, and soluble factors ranging from nutrients to hormones 
(Iskratsch, Wolfenson, & Sheetz, 2014). Based on these tailorable signals, material scientists 
have attempted to augment cell fate conversion by modulating the spatiotemporal stimuli 
experienced by cells (cell-substrate and cell-cell interactions and the paracrine effect) as 
described in Figure 6. Among various strategies to portray niche-like microenvironments in 
the in vitro culture platform, herein, we would only limit our discussion to 4 cell fate 
modulation strategies: 1) physical cues (regulated by substrate topography and elasticity), 2) 
biochemical cues from ECM-like adhesive coatings, 3) electrical cues, and 4) three-
dimensional cues.  
 
2.3.2.1. Physical cues 
Topographical cues enable the modulation of cell’s physical confinement (both in nano- and 
micro-scales) where cells can mechanosense and artificially align themselves to activate 
intricate signal transduction pathways and subsequently facilitate lineage transitions (Costa, 
Lee, & Holmes, 2003; Downing et al., 2013; D.-H. Kim et al., 2010a; Kulangara et al., 2014; 
Yim, Pang, & Leong, 2007; Yoo et al., 2015). For instance, aligned substrates promote the 
differentiation of mesenchymal stem cells to neurons (Yim, Pang, & Leong, 2007) and the 
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conversion of fibroblasts to neuronal lineages (Kulangara et al., 2014; Yim, Pang, & Leong, 
2007). These processes are possibly triggered by force transmitted from the mechanical 
signaling between the cell’s cytoskeleton and substrate, deforming the nucleus and rearranging 
the cytoskeleton (Iskratsch, Wolfenson, & Sheetz, 2014; Missirlis, 2016; Wang, Tytell, & 
Ingber, 2009). The role of patterned substrates not only enhanced the branched morphology of 
neurons, but also promoted the mechanical and electrical signal propagation in the cardiac 
systems (Costa et al., 2003; D.-H. Kim et al., 2010a). Remarkably, a few studies highlight the 
change of epigenetic landscape by enhancing histone acetylation for promoting mature cardiac 
differentiation (Morez et al., 2015) and somatic cell reprogramming to iPSCs (Downing et al., 
2013), obviating the need of chemical compounds. In another study, transducing MEF with 
Ascl1, Pitx3, Nurr1, and Lmx1a on a patterned nanogroove enhanced the direct reprogramming 
efficiency to functional DA neurons via MET-mediated histone methylation (Yoo et al., 2015). 
The nanotopography spontaneously polarized the cell morphology to develop mature DA 
neuronal markers and increase neurite branches. Taken together, these findings address the 
importance of topographical cues on cell fate outcomes by modulating the epigenetic signature. 
Besides the topography of the substrate, its rigidity/elasticity has also been controlled to guide 
the cell fate commitment. The pioneering work from Engler and his colleagues first evaluated 
the role of matrix elasticity on the human MSC fate commitment. Their findings indicated that 
MSCs exhibited more neurogenic, myogenic and osteogenic potentials when cells were 
cultured on a soft matrix (0.1-1 kPa in elastic modulus), a medium stiffness matrix (8-17 kPa), 
and on a rigid matrix (25-40 kPa), respectively (Engler, Sen, Sweeney, & Discher, 2006). 
Along with their seminal work, later works also confirmed that the stiffness of matrix can 
provide potent physical cues at the cell-substrate interface leading to dynamic change in 





















Figure 6. Summarized timeline for biomaterial-mediated cell fate change studies.  
 
  26 
differentiation, and maintenance (Engler, Sen, Sweeney, & Discher, 2006; Gilbert et al., 2010; 
Missirlis, 2016; “Tensional homeostasis and the malignant phenotype,” 2005). The correlation 
between the substrate stiffness and reprogramming efficiency of MEF cells to iPSCs was 
confirmed recently by Choi et al. Upon using a 0.1 kPa soft polyacrylamide hydrogel, more 
Oct4+ and Sox2+ cells were expressed with higher alkaline phosphatase+(AP+) colonies 
compared those cultured on a stiffer (20 kPa) gel via induction of MET (Choi et al., 2016). On 
the other hand, interestingly, without adding any ectopic transcription factors, Guo et al. first 
demonstrated that soft PDMS substrate alone could retain dedifferentiation of HEK-293 cells 
into stem-like cells by forming the embryoid body and exhibiting AP activity via increasing 
the local actin forces (Paszek et al., 2005). A similar study was done by Tan and colleagues 
who investigated the effects of matrix rigidities on direct reprogramming of adipose-derived 
stromal cells (ADSCs) to myoblast-like cells (Tan et al., 2015). With the help of epigenetic 
modulator, 5-Aza-CR, they developed a 3D tunable transglutaminase cross-linked gelatin (Col-
Tgel) system, which can load the chemical stimuli as well as deliver seeded cells for effective 
transplantation of cells in vivo. It was found that 5-Aza-CR sensitized the cells in response to 
the mechanical microenvironment and the medium stiffness (~15 kPa) of Col-Tgel offered the 
significant myogenic potential of cultured ADSCs both in vitro and in vivo. This matrix 
stiffness mimics the niche of the striated muscles (~8-17 kPa) (Engler et al., 2004). After 14 
days of cell transplantation with Col-Tgel scaffold and 5-Aza-CR upon muscle injury, more 
newly formed muscle fibers with less fibrosis were found compared to the ones without the 
scaffold or the epigenetic modulator. These results suggested that microenvironmental cues, 
transmitted from ECM to cells, can epigenetically modulate  cell fate and plasticity to promote 
functional tissue regeneration. Collectively, these data highlight the critical role of substrate-
mediated mechanotaxis on stemness retention and cellular reprogramming by explicitly 
triggering cell shape changes comparable to those using different soluble ligands and factors.   
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ECM, comprised of various cell-secreted factors, plays a critical role in stem cell niche; 
it regulates cell function (proliferation and differentiation) and phenotype by supporting cell 
structure and adhesion to the substrate (Kenry, Lee, Loh, & Lim, 2018). Therefore, coating 
plays a vital role in cell proliferation and differentiation, as well as improving the substrate’s 
biocompatibility (Tong, Bohm, & Song, 2013). Cell interacts with different types of ECM to 
trigger downstream signaling pathway, which leads to different cell behaviors, including cell 
migration, self-renewal, and differentiation (Watt & Huck, 2013). Various bioactive polymer 
substrates have been developed using different surface modification techniques and subsequent 
immobilization of target ligand motifs. Using this approach, Horna et al. observed 8.5-fold 
higher number of iPSC-like colonies upon modifying polystyrene surface with 
pentafluorophenyl methacrylate (PFM) to subsequently tether OSKM encoding lentiviral 
particles, compared to the standard viral transduction method for murine embryonic fibroblasts 
(MEF) (Horna et al., 2012). The reactive ester groups from PFM endowed the covalent binding 
with the amino groups of peptides and proteins, resulting in nearly 100% GFP transduction 
efficiency after 6 hrs of exposure to the tethered infective particles. Likewise, Amanda and her 
colleagues developed RGD peptide and laminin(LM)-decorated poly(ethylene glycol)(PEG) 
hydrogel, which yielded nearly twice as productive reprogramming efficiency as using 
Matrigel for reprogramming cardiomyocyte-like cells from mouse fibroblasts (Smith et al., 
2013). Similarly, Zhou et al. utilized vitronectin peptide grafted polydopamine-based substrate 
for reprogramming human umbilical cord-derived cells and urine-derived cells to iPSCs using 
Sendai viral plasmids (Zhou et al., 2016). The proliferation and pluripotency of hiPSCs were 
not only comparable to the results of Matrigel, but also implementing the xeno-free culture 
platform and non-integrating reprogramming factors offers a clinically more applicable system.  
 Throughout our study, to facilitate the differentiation of NSCs and transdifferentiation 
of fibroblasts on the hydrophobic graphene substrates, ECM proteins LM and fibronectin (FN) 
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were used. LM has the RGD motif, which binds to cells through their integrin receptors and 
selected for its known contribution in neurogenesis, cell migration, axon guidance, and 
myelination (Forrest et al., 2009; Relucio, Menezes, Miyagoe-Suzuki, Takeda, & Colognato, 
2012). Utilizing both adhesive proteins entail cells to strengthen their attachment by positive-
reinforcement of secreting more ECM proteins.  
 
2.3.2.2. Electrical cues 
Electroactive substrates offer a suitable culture platform for excitable cells, such as neurons 
and skeletal muscle cells, for their inherent electrical activity. In this regard, highly conductive 
graphene and its derivatives offer a biocompatible and versatile platform with exceptional 
chemical, physical, and electrical properties. Graphene is defined as a single atomic layer of 
carbons arranged in a 2D hexagonal lattice network. Owing to its sp2-hybridization and thin 
atomic thickness, graphene forms sp2 hybrid orbitals with one s-orbital and two px- and py-
orbitals. These hybrid orbitals in the XY plane lead to a single ! bond, while two " bonds form 
from the perpendicular pz-orbitals. Therefore, graphene naturally renders a high electrical 
conductivity. With this feature, graphene-based substrates may contribute to both passive and 
active electrical stimulation of neighboring neurons, thereby supporting neuronal function and 
maturation (Park et al., 2011; Shah et al., 2014). Recent studies have demonstrated that 
graphene and its derivatives can play active roles in enhancing adhesion, proliferation, and 
differentiation of NSCs (Park et al., 2011; Shah et al., 2014; Yoo et al., 2014). Moreover, 
graphene enables facile functionalization with biomolecules like ECM proteins through 
covalent or non-covalent binding owing to its aromatic network (Kenry, Lee, Loh, & Lim, 
2018). These unique characteristics brought motivation to use these materials for cell fate 
conversion. Yoo et al. first demonstrated graphene-mediated epigenetic reprogramming of 
MEF to iPSCs; inducing MET enriched the expression of the methylated histones and increased 
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the occupancy of Oct4 and Nanog (Yoo et al., 2014). In another study, Shah et al. used the 
graphene oxide substrate for guided differentiation of rat NSCs to oligodendrocytes without 
the chemical inducers. Integrin-mediated signaling led to downstream regulation of focal 
adhesion kinase (FAK). FAK is the primary regulator of integrin-ECM signaling, where it 
mediates cytoskeletal remodeling and process extension during the development of 
oligodendrocytes (Forrest et al., 2009). Likewise, such a fate-guided conductive platform 
would be beneficial for the scale-up production of reprogrammed and differentiated cells.  
 
2.3.2.3. 3D environmental cues 
Engineered 3D cultural platforms have also been explored to provide physiologically relevant 
microenvironments to promote cell fate transition, which is unattainable in 2D culture systems. 
The 2D culture poses limitations in its ability to offer combinations of native milieu 
(biochemical and physical cues) to cells. Therefore, adherent cells result in a low number of 
differentiated populations by experiencing less cell-cell signaling and forming connective 
networks only in a lateral manner (Dingle et al., 2015; Pastrana, Silva-Vargas, & Doetsch, 
2011). Moreover, culturing cells on a rigid culture plate, which is about several orders of 
gigapascal higher than the native brain tissue (ranging from 100 to 1000 Pa) (Elkin, Azeloglu, 
Costa, & Morrison, 2007) makes cells with native behaviors unattainable in a 2D system.  
Several studies have successfully utilized the 3D culture platform to modulate cell fate. 
Noticeable morphological changes were observed when reprogrammed fibroblasts were 
encapsulated by 3D poly(ethylene glycol) (PEG)-based hydrogel and accompanied chromatin 
remodeling and MET transition, essential for initiation of reprogramming (Caiazzo et al., 
2016). A similar approach was used for transdifferentiation of MSC to hepatospheres and 
Schwann cell-like cells using 3D poly(L-lactic acid)-co-poly(ε-caprolactone)/collagen 
nanofibrous scaffold and gelatin-based nerve conduit, respectively (Caiazzo et al., 2016; Uz et 
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al., 2017), undersupplying the growth factors supporting the specific target lineages. When 
compared to the 2D culture platform, the specific hepatic gene expressions were significantly 
increased on a 3D nanofibrous scaffold, and the neurite lengths increased around 2.5-fold on 
3D nerve conduit with a stiffness of ~0.4 ´ 106 Pa. These 3D culture platforms may be a 
potential tool to quickly generate an adequate amount of target cells for further in vivo study 
by augmenting the transdifferentiation of MSCs. Likewise, the 3D culture platform yields high 
surface area and lacks the need for chemical dissociation for passaging the cells. This, in turn, 
preserves and maintains the native behaviors of cells and mimics the native physical 
environment by secreting their own ECM proteins. However, resulting in heterogeneous 
populations from the limited diffusional transport of oxygen and nutrients cause batch 
variations. Therefore, it is imperative to fabricate a 3D culture platform with additional features 
to synergize the environmental cues for its shortcomings to better simulate the niche-like 
environments. For our study, instead of utilizing the 3D culture platform, the host environment 
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Chapter 3. In situ reprogramming of EPCs by 




3.1. Rationale and Significance 
 
In our previous work, Myod1—known as a master regulator for initiating the skeletal 
myogenesis (Weintraub et al., 1989)—was used as a transcriptional target to directly convert 
murine embryonic fibroblasts into skeletal myocytes (Chakraborty et al., 2014). The Myod1-
mediated transdifferentiation supported the notion that direct cell fate conversion can be 
achieved by obviating the need of the intermediate pluripotent cell state through 
dedifferentiation and going through the normal development as depicted by the Waddington’s 
landscape, described in Chapter 2. Background information.  
 The success of our previous work motivated us to follow-up with the studies presented 
in this Chapter. We aimed to extend the CRISPR/dCas9-mediated MYOD1-transactivation of 
the primary human origin as a cell source. For having high proliferation capability through 
clonal expansion, being easily accessible, and being a potential contributor for 
neovascularization and musculature regeneration, EPC was selected as our cell source. Besides, 
sharing the same mesoderm origin, cell fate conversion would be more useful for EPCs (J E 
Ferguson, Kelley, & Patterson, 2005) to skeletal myoblasts—having less epigenetic barriers to 
overcome (Hendry & Little, 2012).  
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 For achieving inter-lineage conversion, an optimized genetic engineering tool was used 
for gain-of-function, as shown in Figure 7. For increasing the utility, codon-optimized and 
humanized CRISPR/dCas9, dual fused with VP64 transactivation domains, was used to target 
the transcriptional activation of MYOD1. Multiple gRNAs were designed to be recruited to the 
MYOD1 loci, and co-delivery was further optimized depending on the most elevated target 
gene expression level. Moreover, the tetracycline-inducible expression system yielded 
temporal activation of the myogenesis program upon the administration of dox. All elements 
were co-delivered via lentivirus to establish the reprogrammable EPCs—transduced with 
CRISPR/dCas9, gRNAs, and m2rtTA.  
 To augment the therapeutic efficacy from the given number and volume of 
reprogrammable EPCs, we re-purposed our cells’ fate to skeletal myoblasts. Instead of 
terminally differentiated cells, myoblasts, which self-renews would increase the chance of cell 
survival and engraftment. Besides, for enriching the CRISPR/dCas9-transduced EPCs to 
uniform cell populations, flow-assisted cell sorting (FACS)-mediated selection was performed 
based on its reporter gene, a blue fluorescent protein (BFP), expression. We posited that under 
the dynamic in vivo microenvironmental cues, these cells could reprogram in situ and promote 
the restoration of damaged muscles. In situ reprogramming is beneficial as implanted cells can 
generate target functional cells by interacting with the secreted soluble factors as well as the 
neighboring cells at the injury sites by recapitulating local microenvironmental conditions. 
Therefore, along with the type and condition of the neighboring cells, the microenvironmental 
cues at an injured region may critically determine the identity of reprogrammed cells and their 
regenerative capacity (Grande et al., 2013; Niu et al., 2013). 
  Collectively, dCas9-based endogenous transcriptional activation of the target gene 
allows cell-fate engineering, which mimics the natural development process to instruct 
stem/progenitor cells to differentiate unlike using the forced ectopic expression induced by 
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transcription factor delivery. Herein, we induce transdifferentiation in situ in a native context 
to provide collective biochemical and physical signals from the niche-like environment in vivo, 
which cannot be provided from in vitro. With efficient and versatile features to modulate 
multiple target loci, dCas9-mediated cell-based therapy would provide broad clinical utility for 
treating various types of injuries and genetic diseases.   









Figure 7. Graphical abstract of summarizing the findings of Chapter 3. In situ 
reprogramming of EPCs by transactivation of endogenous MYOD1 using the 
CRISPR/dCas9 system for utilizing the in vivo microenvironmental cues to achieve in situ 
reprogramming of MYOD1-transactivated EPCs to restore the notexin-induced muscle injury. 
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3.2. Methods 
3.2.1. Cell isolation and maintenance 
3.2.1.1. Isolation and culture of EPCs from umbilical cord blood (UCB)  
As shown in Figure 8, primary EPCs were enriched and populated from the PBMCs, 
isolated from the human UCB (New York Blood Center) using the well-established density 
gradient separation protocol (Mead, Prater, Yoder, & Ingram, 2008). Briefly, the day before 
isolation, a 6-well plate was coated with 1 ml of 50 μg/ml rat tail collagen I per well overnight 
at 37 °C. On the next day, Histopaque-1077 was used as a density gradient medium for the 
diluted UCB with Hank's Balanced Salt Solution (HBSS) at the 1:1 ratio. For the PBMC 
isolation, the diluted blood was slowly added to the Histopaque-1077 at an equal ratio and was 
centrifuged for 30 min at 740 g with no brake. Then, the PBMC layer from the buffy coat was 
collected after three rounds of washing steps with the EPC basal media at the ratio of 10:1, 
followed by the centrifugation for 10 min at 515 g with a high brake. After the final washing 
step, the PBMCs were resuspended in a fully supplemented culture media, EGM-2 (Lonza, 
CC-3162), and seeded on a pre-collagen-coated plate. The media was changed daily at the 
speed of 4-5 seconds/ml for the first week. Then, when the EPC colonies were observed 
between Day 4 and 14 (varied by the UCB batch), they were propagated accordingly with 0.05 
% Trypsin/EDTA and trypsin neutralizing solution (TNS; Lonza) and re-plated on a collagen-
coated plate at the density of 3000-5000 cells/cm2 for further expansions. Throughout all the 
experiments, EPCs and transduced EPCs were maintained by replenishing EGM-2 media every 
two days. For freezing them, 40 % of FBS, 10 % of DMSO, and 50 % of media were used.  
 
3.2.1.2. Human skeletal myoblast and iSkM expansion 
The protocol for expanding human myoblast cells (Gibco, A12555) was adapted from (Darabi 
et al., 2012). Firstly, the flasks were coated with 0.1 % porcine gelatin and cells were seeded 
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at the density of 5000 cells/cm2. The media was replaced for every 2 days with a myogenic 
induction media, consisted of Iscove's Modified Dulbecco's Medium (IMDM; ThermoFisher 
Scientific, 12440053) with 15 % fetal bovine serum (FBS; Atlanta Biologicals), 10 % horse 
serum (HS; Sigma, H1138), 1 % chick embryo extract (Fisher Scientific, 100-163P/10), 50 
μg/ml ascorbic acid (Sigma), 4.5 mM monothioglycerol, 10 μM Rho-associated, coiled-coil 
containing protein kinase (ROCK) inhibitor (for 24 hours; Stemgent, 04-0012-10), and 
gentamicin (ThermoFisher Scientific,15750060). During the reprogramming, a 1:1 ratio of 
EGM-2 media and muscle induction media was replenished with fresh 3 μg/ml of doxycycline 
(dox; Sigma, D3447) every other day. Muscle induction media was composed of DMEM with 
high glucose (DMEM-HG; ThermoFisher Scientific, 11960044), supplemented with 2 % HS, 
sodium pyruvate, GlutaMAX, penicillin/streptomycin (P/S), and β-mercaptoethanol. The same 
passaging method was used as EPC detachment.  
 
3.2.2.  Dox-inducible VdC9BV and gRNA designs and constructions 
The MYOD1 locus-specific gRNAs were designed in silico similarly as described previously 
(Chakraborty et al., 2014). Briefly, the UCSC genome browser tracks (Feng Zhang Lab, MIT) 
were utilized to target the genome within 1000 bases upstream of the MYOD1 transcription 
starting site (TSS)—chr11:17,741,110-17,743,678. The following gRNA-targeted sites (from 
5’ end to 3’ end) were used in this study:  
 
• gRNA1(+strand chr11:17740194-17740213): TTGACTCAGCACCGCGAGTG - ~ 1000 
bps from TSS 
• gRNA2(-strand chr11:17740506-17740525):  CCGAGACAAACGGGTCGTAG - ~ 600 
bps from TSS 
• gRNA3(+strand chr11:17740919-17740938):  ACCTAGCGCGCACGCCAGTG - ~ 200 
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bps from TSS 
• gRNA4(-strand chr11:17740903-17740922):  AGGTCCCCTACCGGGCAGGG - ~ 200 
bps from TSS 
• gRNA5(+strand chr11:17740836-17740855): GAGGTTTGGAAAGGGCGTGC - ~ 250 
bps from TSS 
 
The gRNAs 1, 3, and 5 were selected to target the positive strand of the genome while 
gRNAs 2 and 4 were selected to target its opposite strand. Among 5 different candidates, the 
best combination (gRNAs 1, 2, and 4) was selected for the maximum activation of the 
endogenous MYOD1 throughout the experiments.  
For constructing VP64dCas9-BFPVP64(VdC9BV), a humanized pdCas9-BFP plasmid 
was purchased from Addgene (#44247) for the insertional cassette. Two gBlock DNA 
fragments (Integrated DNA Technologies) were used to fuse dual VP64 transactivator 
domains: 1) N’-VP64, FLAG-tag, and a linker; and 2) VP64, FLAG-tag, and a nuclear 
localizing signal (NLS), and a linker. These fragments were cloned into a lentiviral Tet-O-
FUW backbone (Addgene, #27152), encoding the tetracycline-inducible expression system, by 
a four-way ligation reaction. This fused Tet-O-FUW-VdC9BV plasmid was deposited and now 
available through Addgene (#62195). The insertional cassette of the genomic target sequences 
was synthesized with human U6 promoter as previously described (Mali et al., 2013) in the 
form of the U6 promoter + 20 bp gRNA targets (5 sets of gRNAs) + 3 bp PAM sequence for 
the type II CRISPR system (NGG). The BsmBI restriction site was added to the distal end of 
the promoter to generate complementary sticky ends. Subsequently, these synthesized gBlocks 
were individually cloned into the FUGW lentiviral plasmid backbone (Addgene, #14883), 
double digested with PacI and XhoI to replace the ubiquitin (promoter)-GFP cassette. All 
ligation reactions were conducted with Q5 High Fidelity DNA polymerase (New England 
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Biolabs), and cloning primers to PCR amplify and purify the products using the Qiagen PCR 
purification kit. 
 
3.2.3. Lentiviral production and transduction for engineering 
reprogrammable EPCs 
As described previously (Chakraborty et al., 2014), lentiviral particles, transfected individually 
with the dox-inducible VdC9BV and M2rtTA, and each U6-gRNA candidate, were produced 
from HEK293T or HEK293T/17 (ATCC, CRL-11268) cells by the standard transfection 
method of calcium phosphate precipitation (SignaGen Laboratories, CalFectin™ ) using the 
second-generation lentiviral packaging plasmids: psPAX2 (Addgene, #12260) and pMD2.G 
(Addgene, #12259). Briefly, HEK293T cells were maintained using DMEM-HG, 
supplemented with 10 % FBS, GlutaMAX, sodium pyruvate, MEM non-essential amino acids 
(NEAA), and P/S. To transfect the plasmids of interest (VdC9BV, M2rtTA, and gRNA 
candidates), HEK cells were cultured on 0.1 % porcine gelatin-coated T-75 flasks (coating for 
at least an hour) to maintain a sheet of even HEK293T population. An hour before plasmid 
transfection, a sufficient amount of media was replenished to prevent serum starvation. In a T-
75 flask, each plasmid of interest was prepared for lentiviral packaging by diluting 9.5 µg of 
the plasmid of interest, 3.3 µg of PMD2.G and 6.2 µg of psPAX2 into 625 µl of DMEM-HG 
basal media. Likewise, 58.5 µl of CalFectin was diluted with 625 µl of DMEM-HG. Diluted 
CalFectin was added to diluted plasmids mix and incubated for 15 min at room temperature 
(RT) after rigorous vortexing to be added to each flask drop by drop. After 5 hours of 
incubation, fresh media was replenished to remove calcium residues from the media and media 
was collected in three consecutive days, starting from 28 hours post-transfection. Collected 
lentiviral supernatant was centrifuged at 1000 rpm for 5 mins at 4 °C for removing cell debris. 
Subsequently, the supernatant was filtered by a 0.45 µm-filter and a Luer-lock syringe and 
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concentrated (up to 50 times) with Amicon Ultra-15 centrifugal filter unit (MilliporeSigma, 
UFC910024) at the speed of 3400 rpm for 20 mins at 4 °C. Concentrated virus was aliquoted 
and stored at -80°C until future use.  
For assessing the viral titer, qPCR Lentivirus Titration Kit (Abm, LV900) was used by 
following the manufacturer’s procedure to detect the signal based on the 5'LTR region of the 
lentiviral plasmid backbone. Accordingly, the multiplicity of infection (MOI) was calculated 
based on optimized after 5 days post-transduction to improve its efficiency while not 
significantly affecting the cell viability.  Based on the results, human EPCs were transduced 
one day after seeding with the viral concentrates (M2rtTA, VdC9BV, gRNA1 through 5) and 
4 µg/ml of polybrene (Sigma) at the MOI of 40, 10, and 10 for VdC9BV, M2rtTA, and gRNAs, 
respectively. After a day, fresh media was supplied and cultured accordingly based on the 
analysis.  
 
3.2.4. In vitro characterization of EPCs and enriched iSkMs 
3.2.4.1. Immunophenotyping of isolated EPCs 
The immunophenotypes of the isolated EPCs were confirmed by the FACS CantoII flow 
cytometer (BD Biosciences). The surface antigen markers and isotype controls were all 
purchased from BioLegend: human APC-CD31 (303115), human PE-CD144 (348505), human 
FITC-CD14 (325603), human PE-CD45 (304007), mouse PE-IgG1, κ (400111), mouse FITC-
IgG1, κ (400109), mouse APC IgG1, κ (400119), and mouse PE IgG2a, κ (400213). For further 
validation, EPC characterization kit (Lonza) was also used to confirm the expressions of EPC 
markers, including anti-mouse CD31, anti-mouse CD146, anti-rabbit Flk-1, and anti-rabbit 
vWF by following the standard staining protocol. Briefly, it uses 4 % paraformaldehyde (PFA) 
to fix the cells, permeabilize cells using 0.2 % Triton X-100, blocking with 10 % goat serum 
(GS), and subsequently staining with the primary antibodies overnight and fluorescent-labeled 
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secondary antibodies in the following day along with DAPI. Fluorescent images were all taken 
with Nikon TE2000 fluorescent microscope or Nikon A1 confocal laser microscope system 
using the NIS-Elements software. 
 
3.2.4.2. gRNA optimization for promoting reprogramming efficiency  
After transducing EPCs with VdC9BV and M2rtTA, cells were infected with various 
combinations of gRNAs with 5 days of dox induction for analyzing the gene expression using 
qRT-PCR and RT-PCR. Eleven combinations were tested against the negative control, EPC 
ectopically forced to express murine Myod1 transcription factor. To conduct qRT-PCR, 
RNeasy Mini Kit (Qiagen, 74104), iScript cDNA synthesis kit (BioRad), and SYBR green 
chemistry (BioRad, 172-5272) were utilized. The optimized gRNA mix (as designed from 
3.2.2.) was selected based on the highest endogenous MYOD1 expression level relative to the 
control using the 2-ΔΔCT method. The primer sets used for endogenous MYOD1 were: 
CTTTGCTATCTACAGCCGGG (forward) and GAGTGCTCTTCGGGTTTCAG (reverse); 
and GGAGCGAGATCCCTCCAAAAT (forward) and GGCTGTTGTCATACTTCTCATGG 
(reverse) for GAPDH (throughout Chapter 3. In situ reprogramming of EPCs by 
transactivation of endogenous MYOD1 using the CRISPR/dCas9 system and Chapter 4. 
Enhancing the neural cell fate commitment by deploying biochemical cues and substrate-
mediated electrophysical cues studies). Upon optimizing the gRNA combinations, primers in 
Table 1 were used for RT-PCR analysis for testing the profiles of the myogenic regulatory 
factors after 5 days of dox-added iSkMs compared to control (transduced EPCs in the absence 
of gRNA cocktails) where GAPDH was used as a reference gene for normalization. 
 
3.2.4.3. Evaluation of the flow-assisted cell sorting-mediated selection of 
iSkMs 
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After optimizing the gRNA cocktail targeting the locus of endogenous MYOD1, to further 
promote the reprogramming efficiency, FACS was utilized for selecting the VdC9BV and 
M2rtTA transduced EPCs. After 5 days of dox induction, transduced EPCs were sorted by the 
expression of BFP using the BD InfluxTM cell sorter (BD Biosciences). This was followed by 
subsequent transduction of gRNA cocktails and proliferated up to passage 13 for all the in vitro 
and in vivo experiments. Transduced cells were cultured with fresh dox in the low serum 
differentiation media every other day up to a month for examining the reprogramming potential 
to develop iSkMs.  
After establishing reprogrammable EPCs—transduced with VdC9BV, M2rtTA, and 
gRNA combinations—, their reprogramming efficiency was analyzed by immunostaining the 
reporter genes encoded by VdC9BV. iSkMs were induced for 7 days and stained with FLAG 
(Cell Signaling Technology; 14793S) to identify its co-expression with DAPI. A total number 
of %FLAG+ cells were analyzed using ImageJ. After another week of dox induction, MYOD1 
(Pierce; MA1-41017; 1:50) and BFP expression was evaluated compared to the original EPC 
using FACS CantoII and FACS AriaII™ flow cytometer (BD Biosciences), respectively. All 
the FACS data analysis was performed using FlowJo (Tree Star) and Microsoft Excel.  
Expression of the lineage-specific mature marker was additionally assessed for a long-
term in vitro induction in the presence of dox. iSkMs were stained with muscle-specific marker, 
MHC (Developmental Studies Hybridoma Bank, MF20; 1:100) and MYOD1, and EPC 
marker, anti-rabbit vWF (Dako, A0082; 1:200) both in the absence and presence of dox. The 
gene expression level of iSkMs was also compared with other cell types, including EPC control 
(negative control) and human skeletal myoblasts (positive control). Primers used for the long-
term in vitro the direct reprogramming of EPC were shown in Table 2 and as a reference gene, 
18s rRNA was used for normalization.  
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3.2.1.1. RNA-Seq analysis 
The library and genomic mapping were done from the Columbia genome center upon 
submitting the triplicate samples of isolated total RNA from human myoblasts, EPCs, and 5-  
day dox-induced iSkMs. The Venn diagram was prepared based on the differential gene 
expression profile between the experimental groups against the donor cell, performed with 
DESeq2 using the counts files obtained from genomic mapping. Utilizing these results of the 
differential expression analysis, we performed a gene ontology analysis to determine which 
gene ontologies were altered in each experimental group as compared to the original 
undifferentiated cells. The normalized enrichment score (NES), nominal P-value, and false 
discovery rate (FDR) were indicated in each enrichment plot.  
 
3.2.2. Animal care and cell transplantation  
3.2.2.1. Breeding and validation of the immunodeficient NOD scid mice model  
In vivo study was conducted following the animal care and experimental guidelines approved 
by the committee at Dankook University (DKU), Korea. Followed by the protocol (#15-047), 
all animals were bred and housed in a level 2 biosafety animal facility with a specific pathogen-
free environment, and they received food and water ad libitum.  
Total 4 male and 17 female NOD.CB17-Prkdcscid/J (NOD scid) mice were purchased 
from JAX (#001303) at the age of week 6. They were mated at the ratio of 1:3 or 1:4 (male: 
female) per cage for a week. After a week, male mice were isolated from the female mice for 
a week to verify their pregnancy. Once the mouse was pregnant, it was separated from other 
mice until her offspring reached 4-weeks-old and segregated based on their identified sex. After 
isolating pups from their mothers, mothers were not mated for a month to provide them a break. 
The mating process started at the female age of week 7, repeated only twice in their lifetime, 
and sacrificed as they aged. Each mouse was traced by the ear tag and cage number to prevent 
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the inbreeding, leading to a genetic defect or premature death of the animal. Each cage 
supported up to 5 female or 4 male mice and bedding was replaced twice a week. Following 
this inhouse breeding schedule, all experiments were conducted with 8- to 12-week-old female 
mice (up to F3 generations) for having less complement activity (Shultz et al., 1995) and a 
lower rate of myogenesis than male mice (Manzano et al., 2011).  
To test the feasibility of the injection protocol and the 2-week xenograft study, a 
preliminary study was conducted with 0.5 million transduced EPCs (suspended in 15 µl of 
saline), injected into the right hindlimb while saline was injected into the opposite intact tibialis 
anterior (TA) muscle (n = 3). Cell injection protocol and immunostaining analysis of the 
cryosectioned-muscles were followed, as explained below in detail (3.2.5.3. and 3.2.6., 
respectively). Based on these preliminary results, to further increase the survivability and 
engraftment efficiency of the injected cells, the cell number was increased to 1 million, and the 
affected lesion site within the myofibers was enlarged by insulting the muscle with systemic 
injection of myotoxin.  
 
3.2.2.2. Establishment of the myotoxin-induced skeletal muscle injury in vivo 
model 
For the muscle injury model, two different myotoxins were tested following the same injection 
protocol. Mice were anesthetized by the inhalation of 1-5 % isoflurane/O2. For injecting 
myotoxins, a 26.5-gauge syringe was used for the injection at the speed of 20 μl/min. Either 50 
µl of 0.5 % bupivacaine (Tokyo Chemical Industry, B3925) or 50 µl of 2 µg/ml Notexin 
(Latoxan, L8104) was diluted in saline and injected i.m. at both sides of the TA muscle.  
 
3.2.2.3. Cell transplantation  
A day after myotoxin injection, 1 million cells (suspended in 15 µl of saline) of either 
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transduced EPCs or human myoblasts were injected i.m. along the length of TA muscle to 
evaluate their in vivo therapeutic potentials (engraftment and maturation into skeletal 
myotubes). All mice were anesthetized as mentioned above and all cell injections were 
conducted with the 33-gauge Hamilton syringe concurrently with needle withdrawal at the 
speed of 2 μl/min. A needle was initially injected into the lower end of the TA muscle and 
longitudinally pushed through until 3 mm below the proximal end of the tendon. Then, the 
syringe was pushed across the muscle as it was withdrawn. One or both legs were injected with 
either cells or saline (for the control group). Total groups were: 1) saline-injected group as a 
negative control; 2) human myoblasts-injected group as a positive control (n = 6); 3) 
transduced EPC-injected group with dox as a treatment group (n = 8); and 4) transduced EPC-
injected group without dox as a control (n = 8). For a month, either 7.5 % sucrose water with 
or without dox was given to the reprogramming and control groups, respectively. Both types 
of water were replenished twice a week.  
 
3.2.3. TA muscle isolation and analyses 
3.2.3.1. Muscle extraction and cryosectioning process for preparing 
histological analyses  
TA muscles were harvested 4 weeks after cell injections and the mice were euthanized by CO2 
inhalation as a primary method followed by cervical dislocation. Collected TA muscles were 
all processed by snap-freezing them in liquid nitrogen-cooled 2-methylbutane (Sigma) for 3 
seconds and storing in -20 °C for cryosection, or in liquid nitrogen for RNA extraction later. 
For cryosection, one-thirds of the TA muscle was perpendicularly embedded into the O.C.T. 
compound (Sakura® Finetek) and sliced immediately without fixing the muscle. The cryostat 
(Leica) was used to obtain 10 μm transverse muscle sections serially at -25 °C. Each 
cryosection was mounted on silane-coated glass slides for further histology and 
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immunocytochemistry analyses. 
 
3.2.3.2. Morphometric evaluation of the fibrosis, myogenesis, and myofiber 
regeneration 
Prepared cryosections were stained with Hematoxylin and Eosin (H&E) and Sirius red 
(Abcam, ab15068) for the histological assessments and quantification of fibrosis followed by 
the manufacturer’s protocol. Hematoxylin stains for the nuclei and chromatin (in blue/violet 
and dark blue/black, respectively) and Eosin stains for the cytoplasm, muscle fibers, and red 
blood cells (in pink, deep pinky red, and in red, respectively). Sirius red stain intercalates into 
the protein structure of collagen (types I and III) fibrils in red and stains muscle fibers and 
cytoplasm in yellow.  
 For evaluation of the fiber number and total fiber area, average fiber size (obtained by 
fiber number divided by the total fiber area) and %regenerative fibers (obtained by counting 
the percentage of the centronucleated myofibers amongst total fiber numbers), three 
nonconsecutive sections of H&E stained slides were selected and images were taken at three 
random microscopic fields (200X) per muscle. As myofiber shapes were not in a perfect circle, 
instead of measuring the wider diameter size of the myofibers as other previous studies 
quantified, myofiber area was estimated. Such quantification was performed by drawing 
individual fibers with the drawing pad pen and going through multiple rounds of threshold and 
masking tools to exclude void areas and blood vessels using the programmed Image J macros. 
All the fibers at the edges were excluded for both counting and area measurements. Similarly, 
for quantifying the %area of fibrosis, 2-3 microscopic fields (100X) were randomly selected 
and analyzed by quantifying the percentage of the deposited collagen fiber (in red) over the 
total myofiber area (in yellow). All image analyses were taken with the bright-field microscopy 
and conducted with 3 biological replicates analyzed by Image J and Wacom drawing pad 
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(CTH-470) to set the boundary of myofibers for the morphometric evaluation.  
 
3.2.3.3. Immunofluorescent staining for cryosectioned-muscle tissues 
Tissues mounted on silane-coated glass slides were fixed in 4 % PFA for 10 mins at RT, rinsed 
with PBS for 5 min. Next, glass slides were applied with rubber cement to prevent the 
overflowing of liquids during the staining process. In addition to the normal staining procedure, 
to reduce the background autofluorescence of the cryosectioned-muscle tissues, they were 
incubated with 0.4 % pepsin (in 10 mM HCl) for 10 min at RT. Then, the tissue was 
permeabilized with 0.3 % Triton X, rinsed with PBS twice for 5 min, blocked with 2 % normal 
GS for 1 hr at RT, and stained with primary antibodies at 4 °C overnight followed by the 
staining of secondary antibodies and DAPI the next day. The primary antibodies used are anti-
rabbit FLAG (Cell Signaling Technology, 14793S; 1:400), anti-mouse human nucleus (hNu; 
MilliporeSigma, MAB1281; 1:100), and anti-rat laminin (Abcam, Ab2466; 1:50). The 
secondary antibody (1:200) used were all purchased from ThermoFisher Scientific: Alexa 
Fluor 488 goat anti-mouse/rabbit IgG (A-11001/A-11008), Alexa Fluor 594 goat anti-
rabbit/mouse IgG (A-11037/ A-11032),  and Alexa Fluor 647 goat anti-rabbit IgG (A-21245).  
For evaluating the contribution of non-reprogrammed EPCs on neoangiogenesis, 
muscle cryosections were additionally stained with the endothelial cell markers, anti-mouse 
CD31 (Santa Cruz; SC1506; 1:200) and anti-rabbit vWF. The percent or area density of 
capillary was quantification by measuring the total number of cells or the cross-sectional area 
(mm2) occupied by the numbers of CD31+ or vWF+ cells using Image J. Total 4 random 
microscopic fields (200X) were enumerated to analyze the data.  
 
3.2.4. Statistical analysis 
All analyzed data were represented as the mean ± standard deviations (stdev), and statistical 
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analyses were performed by a two-tailed unpaired student t-test for the comparisons between 
two groups. For comparing multiple groups, either one-way or two-way analysis of variance 
(ANOVA) was used with the post hoc analysis of Tukey’s or Sidak’s multiple comparison 
tests, respectively, using GraphPad Prism 6. Statistical significance was denoted as: * for p < 
0.05, ** or ++ for p < 0.01, *** or +++ for p < 0.001, and **** or ++++ for p < 0.0001.  
  49 
3.3. Results and Discussion  
 
3.3.1. Isolation and characterization of EPCs from UCB  
The UCB was used as a systemic source of primary human EPCs using the density gradient 
separation protocol, as depicted in Figure 8 and characterized by immunophenotyping. Based 
on this result, it was confirmed that the isolated EPCs express EPC lineage-specific markers, 
including CD31, CD144, CD145, Flk-1, and vWF, while not expressing CD45 and CD14 
(Figure 9)(Mead, 2008).  
 
3.3.2. Constructing dox-inducible VdC9BV and gRNAs to engineer 
reprogrammable EPCs 
Lentivirus, encoding VP64dCas9-BFPVP64(VdC9BV), M2rtTA, and combinations of gRNAs to 
activate endogenous MYOD1 upon dox induction, were produced as previously explained 
(Chakraborty 2014) and as shown in Figure 10. The tetracycline-inducible expression system 
was used to design the dCas9 plasmid to confer a temporal control of activating the gene of 
interest. In contrast, five gRNA sequences were designed with the continuous expression of to 
target different positions proximal to the endogenous MYOD1 transcription start site and tested 
for the best combinations by qRT-PCR. With the “G8” gRNA combinations (combinations of 
gRNAs 1, 2, and 4), MYOD1 was activated around 130-fold higher than the control EPCs 
(Figure 11A) after 5 days of dox induction. Thus, this combination was used throughout all the 
experiments in Chapter 3. In situ reprogramming of EPCs by transactivation of endogenous 
MYOD1 using the CRISPR/dCas9 system. Transduction with these gRNA cocktails was also 
qualitatively assessed with RT-PCR to confirm the upregulation of other skeletal muscle-
associated markers (Figure 11B). Once the myogenic fate was validated for iSkMs by the   










Figure 8. Schematic diagram of isolating EPCs from the UCB using a density gradient 
separation protocol .  
Figure 9. Isolated primary human EPC express EPC-specific markers. Immunophenotyping 
of EPCs using immunostaining (top) and flow cytometry (bottom). 
 




























Figure 11. Confirming the activation of the myogenic differentiation program, 
initiated by the transactivation of the MYOD1 in EPCs. Optimizing the gRNA 
cocktails based on the expression of endogenous MYOD1 in tranduced EPCs, 
induced with dox for 5 days (A) using qRT-PCR and validating the expression of 
other myogenic-associated markers using RT-PCR (B) upon transducing the EPC 
with G8 gRNA cocktail. *: p < 0.05, **: p < 0.01,and ***: p < 0.001.  
Figure 10. Constructed lentiviral plasmids for establishing reprogrammable 
EPCs. Plasmid maps of VdC9BV (top) and gRNAs (bottom) in a lentiviral plasmid 
vector driven by CMV and U6 promoter, respectively. 
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expression of MYOD1, VdC9BV and M2rtTA-transduced EPCs were sorted using the BFP 
(Figure 12A) reporter gene from the VdC9BV construct and expanded for further studies. A 
sorting step was necessary as transduction efficiency was low (4.06 %), presumably due to the 
large size of the VdC9BV plasmid (13.8 kb) with the co-delivery of gRNA mixtures using the 
lentiviral delivery system (Figure 12B and C). For validating reprogramming efficiency of the 
BFP-sorted EPCs, they were fed with an equal ratio of skeletal myoblast induction media and 
the EPC media in the presence of dox until the cells were characterized (Figure 13).  
 
3.3.3. Short-term in vitro characterizations of the MYOD1 
transactivated-EPCs 
3.3.3.1. Immunofluorescence and flow cytometry analysis 
 For staining, FLAG epitope (DYKDDDDK) was used to trace the VdC9BV-transduced 
EPCs for being expressed twice as much in the VdC9BV construct compared to the BFP 
(Figure 10). With 7 days of continuous dox induction, approximately 30 % were FLAG+ cells 
(Figure 14), while the intensity of BFP expression was low under the fluorescent microscope 
(data not shown). An additional week of dox induction increased the expression of MYOD1 30 
times more than the control group (cells without dox), and 51 % of cells expressed BFP (Figure 
15). Upon initiating the transdifferentiation process by adding dox, it significantly elongated 
the cell morphology as shown from the steeper slope of the SSC vs. FSC graph, which resulted 
in the heterogeneous cell population.  
 
3.3.3.2. RNA-Seq analysis 
To further corroborate and quantify the committed iSkMs, global gene expression patterns 
were analyzed for 25,560 genes. The iSkMs had 1903 genes overlapping with those expressed 
by the skeletal myoblasts (Figure 16A). Among all genes expressed by iSkMs, 8127 genes   





















Figure 12. Sorting of VdC9BV-transduced EPC using BFP. Schematic diagram of the cell 
sorting process (A). Before (B) and after (C) BFP sorting of the transduced EPCs. 
Figure 14. The expressions of FLAG-tag+ cells with and without dox induction for 7 days. 
 
Figure 15. Expressions of MYOD1 and BFP on the transduced 
EPCs without and with dox for 14 days. 
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were significantly different from the donor EPC genes (p < 0.05) and from them, skeletal 
myoblasts gene sets of the genetic regulatory network (GRN) were selected from the 
significantly downregulated or upregulated ones against the original EPCs. These 
downregulated and upregulated genes by the skeletal myoblasts were negatively (NES = -6.56) 
and positively enriched (NES = 11.44) by iSkMs, respectively (Figure 16B). This indicates that 
iSkMs have similar global gene expression pattern as our positive control, skeletal myoblasts. 
Among these gene sets of GRN, the most upregulated and downregulated genes were 
represented as a heat map (Figure 16C). Among all genes, MYOD1 was the most elevated (230-
fold) gene expressed, which signifies the activation of a master regulator for myogenesis to 
convert the EPC fate to the myogenic state. Owing to the early phase (day 5) of the lineage 
conversion, other mature myogenic transcripts were not significantly activated yet, but it was 
noticed that the EPC-specific markers, such as vWF and CD34, were downregulated compared 
to the parental ones. Additionally, distinctive transcriptional signatures of the original donor 
cells (EPCs), iSkMs at day 5, and the target cells (skeletal myoblasts) were exhibited in four 
quadrants by the PCA. As represented by dotted arrows, significant dimensional separation 
across different groups exemplified the transition of iSkMs diverging away from the donor 
cells and moving towards the target cells (Figure 16D). However, it was noticeable that the 
gene expression profile within the same sample group clustered similarly, representing low 
variability among triplicates. Collectively, RNA-Seq results confirmed the early 
transactivation of the MYOD1 (within 5 days of dox induction), known to lead the activation 
of downstream myogenic-associated genes consequently. 
 
3.3.4. Long-term in vitro characterizations of the MYOD1 
transactivated-EPCs 
After confirming the activation of MYOD1 during the initial reprogramming process   























Figure 16. Comparing the transcriptomes of EPC, 5-day dox-induced iSkMs, and 
skeletal myoblasts.  Differentially expressed genes for skeletal myoblasts and iSkMs against 
the original EPC (A). Both negatively (left) and positively (right) enriched global gene 
expression patterns of iSkMs. Heat maps representing the changes of gene expression levels 
for the skeletal myoblasts and iSkMs days of post-induction compared to original EPC (C). 
The PCA of whole genome expression profiles of EPC control (blue), iSkMs (green), and 
skeletal myoblasts (red) demonstrated the directed shifts of phenotypes toward the target cell 
type. n = 3 was used for each group (D). 
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Figure 17. Long-term iSkMs express mature skeletal muscle cell-associated 
markers in vitro. Expressions of skeletal muscle cell-associated markers for a 
3-week activation of MYOD1 in vitro with dox compared to the transduced EPC 
without dox (A). Scale bar represents 200 μm. Relative change in gene 
expressions compared with EPCs for EPCs, iSkMs (dox-induced for a month), 
and human myoblasts in a log scale of 10 (B). The symbols **** and ++++ 
indicate p <0.001 when compared with parental EPCs and with iSkMs, 
respectively. 
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(Figure 11, Figure 15, and Figure 16C), the myogenic potentials of the transduced EPCs over 
a long-term dox induction (3 weeks) was confirmed by the expression of a mature myogenic 
marker, myosin heavy chain (Myosin)(Figure 17A). Their cell morphology was also signified 
by the multinucleated cell fusions with elongated morphology, whereas the transduced EPCs 
in the absence of dox lacked the MYOD1 activation, thereby maintaining the EPC-specific, 
cobblestone-like morphology. This was further confirmed by the gene expression of iSkMs 
after a month-long dox induction compared to the parental EPCs and human myoblasts as  
positive control by qRT-PCR (Figure 17B). As expected, EPC markers (CD31 and CD105) 
were downregulated for both transduced EPCs and human myoblasts compared to original 
EPCs, while another skeletal muscle associated marker expression was also elevated upon the 
transactivation of MYOD1. However, the mature skeletal muscle marker, myogenin, was not 
overexpressed in iSkMs even after a month of reprogramming, denoting that they were not 
fully matured in the in vitro setting. Thus, implying the limitation of providing the niche-like 
environment in a 2D setting for the complete myogenesis of EPCs by merely transactivating 
MYOD1 in a low serum condition. 
 
3.3.5. Validation of an immunodeficient NOD scid mice model 
To fully promote the myogenic potentials of VdC9BV-transduced EPCs, our strategy was to 
expose them to the orchestrated in vivo biochemical signals similar to the native 
microenvironments by injecting reprogrammable EPCs to immunodeficient host (Figure 18). 
These signals may include secreted proteins, similar extracellular matrix compositions, and the 
elasticity of the tissue, which could further enhance the cell fate commitment to skeletal 
myoblasts. For the host, NOD scid transgenic mice were chosen for being immunodeficient 
(i.e., harboring impaired innate immune activity) with low leakiness and its simplicity in 
breeding homozygous strains in house. The NOD background confers defective cytotoxic   





Figure 18. Schematic diagram of the first approach: using microenvironmental cues to 







Figure 19. Two-week survival and engraftment of the transduced EPCs in the host TA 
muscle of the healthy murine NOD scid model. HNu stains for human origin cell and laminin 
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activity of natural killer cells and additional scid mutation (athymic) yields impaired 
development of mature T and B lymphocytes, affecting the adaptive immunity.  
Before accessing the maturation of the reprogrammable EPCs in situ, the survival and 
engraftment of the transduced EPCs were tested in a healthy model of the immunodeficient 
NOD scid mice (n = 3) and muscles were harvested after two weeks. As shown from Figure 
19, immunostained muscle slice validated the survival and functional integration of the injected  
cells to the host tissue, determined by a centronucleated myofiber. Unlike other centronucleated 
myofibers stained by DAPI only, the cell co-immunostained with DAPI and hNu staining 
indicated the implanted cell among other infiltrated host’s cells. While injection took place in 
the absence of the chemically-induced muscle injury, it was hypothesized that during the 
injection process, the large needle diameter would have damaged the host’s intact myofibers. 
Among 0.5 million injected cells exposed to the in vivo microenvironmental cues, only a few 
of them were engrafted for several potential reasons: 1) localized myofiber damage, only 
limited to the needle injection path; and 2) low number of injected cells available to migrate 
towards the injury site, thereby, making the engrafted iSkMs challenging to track. Nonetheless, 
comparing the muscle moist weight between the control (saline) and the cell-injected groups 
(n = 3) both without dox showed a significant difference (p = 0.0116): 36.53 ± 0.50  and 34.23 
± 0.75 mg, respectively. This may denote the inadequate length of the study (2 weeks) for 
restoring the damage caused by the invasive injection process. To address these limitations 
collectively, we examined the pathologically-relevant in vivo microenvironment of the host for 
increasing the regeneration capacity of the injected iSkMs.  
 
3.3.6. Establishment of the notexin-induced skeletal muscle injury in 
vivo model   
To better mimic the pathophysiological conditions of the injured muscle in vivo, various injury 
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models were assessed based on the established methods, using: 1) physical injury (e.g., 
laceration or crush), 2) chemical-based injury (e.g., cardiotoxin, notexin, or bupivacaine), and 
3) cryoinjury (e.g., liquid nitrogen). For yielding a consistent, controllable, and reproducible 
injury model across each host, the chemically-induced procedure was chosen. At first, 0.5 % 
of bupivacaine was tested, but from the preliminary results after a month of post-injury, no 
significant difference in average fiber size was observed across the treated and non-treated 
(saline control) mice groups (data not shown). To induce more severe insult than bupivacaine, 
stronger chemical notexin, isolated from snake venom, was selected for our study. 
To detect the extent of damage, notexin-injected muscles were harvested after a day to 
compare the associated pathological changes to its control. The color, myofiber structure, and 
the fibrotic scar formation all indicated a significant difference between the intact and injured 
sites at one-day post-injury (Figure 20). Injecting notexin destroyed the sarcolemma structures 
of the muscle fibers, while immune cells subsequently were recruited to repair the affected site. 
After establishing a notexin-induced injury model, one million cells were transplanted 
one-day post-injury using a stereotaxic syringe pump installed with the Hamilton syringe to 
regulate the speed of injection. Until the TA muscles were harvested after a month of injury, 
water with or without dox was delivered orally to different groups of NOD scid mice to elicit 
in situ reprogramming at the injured site (Figure 20). A day of the interval was given after the 
chemical and invasive injury induced by notexin and the needle to deliver transduced EPCs for 
preventing them from getting exposed to an acute proinflammatory microenvironment, where 
orchestrated signals of proinflammatory cytokines (e.g., TNF-α and IL-1β) are secreted by the 
necrotic myofibers and muscle satellite cells. These danger signals serve as chemoattractants 
to recruit immune cells (macrophages and monocytes) for the skeletal muscle repair (Chazaud 
et al., 2003). At the same time, it was kept as short as possible to prevent the host’s muscle 
satellite cells—competing entity against iSkMs—to rapidly enter the mitotic cycle to   




















Figure 20. The establishment of the notexin-induced TA 
muscle injury model. Schematic diagram of the in vivo study 
scheduled for the NOD scid mice model (top) and the 
variation in muscle phenotypes (morphology and H&E 
stained results) of the intact muscle (control) and injured one 
at 1 day post-injury (bottom).  
Control Notexin 
Figure 21. Histological evaluation of the regenerated injected sites (white triangle) for 
both intact muscle (2-week post-injection) and notexin-insulted muscle (1 month post-
injury). Abbreviations: DCell, dox-given cells; NDCell, no dox-given cells; hSkM, human 
skeletal myoblasts. Scale bar indicates 100 μm. 
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participate in the myogenic repair pathway for re-establishing the muscle structure and its 
function (Collins et al., 2005; Le Grand & Rudnicki, 2007). 
As described in 3.3.5., compared to the intact muscle model with localized invasive 
myofiber damage, more severe and broader myofiber damage was observed for the notexin-
injury model, although the study duration lasted two weeks longer than the preliminary 
engraftment study (Figure 21). More centronucleated myofibers were observed near the 
injection sites (indicated by white triangles) for all the groups in the injury model compared to 
the intact one. This may have increased the engraftment efficiency of iSkM by driving the 
myogenic potential of the transduced EPCs in situ, thereby enhancing the reconstitution of the 
damaged myofibers. Lacking the proper setup, it was not feasible to conduct the muscle 
functional recovery test. Besides, it was challenging to discern the muscle regeneration efficacy 
based on the locomotion of mice as skeletal muscles are highly adaptive tissue (Abresch, Walsh, 
& Wineinger, 1998). Therefore, by one week of post-injury, all mice seemed to adapt to their 
injury by delegating the force applied to the TA muscle and restoring the normal movement. 
Therefore, for the quantitative comparisons of the therapeutic effect across the treatment 
groups, morphometric evaluations were performed by analyzing 2 to 3 random microscopic 
fields per three animals per group.  
 
3.3.7. Morphometric evaluation of the fibrosis, myogenesis, and 
myofiber regeneration 
3.3.7.1. Pathohistological assessments of engrafted iSkMs for regenerating 
damaged myofibers  
Tracing the regeneration of injured muscle after a month, it was observed that injured muscle 
fibers were reconstituted with diverse recovery efficiencies based on the groups implanted with 
saline (negative control), human skeletal myoblasts (hSkM; positive control), transduced EPCs 
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induced with dox (DCell), and transduced EPCs without dox (NDCell). It was noted that the 
saline control and NDCell had severe necrotic fibers (purple myofibers), which suggested the 
incomplete myogenesis. However, more centronucleated myofibers, representing the recently 
regenerated ones, were observed from the groups injected with hSkM or DCell with no signs 
of necrotic tissue formation (Figure 22A).  
Unlike the intact muscle, even after a month of regeneration, not all muscle fibers were 
fully restored to its original state in terms of its number and size. Notexin insult destroyed the 
myofibers, which rendered a void space for immune cells and muscle satellite cells to mitigate 
the inflammatory response and activate the myogenesis for regenerating mature myofibers, 
respectively. During this process, the microenvironment of the stem cell-niche dynamically 
changes. To secure the anatomical position of the damaged myofiber structure, the fibrillar 
structure of ECM proteins get deposited mainly from mesenchymal stromal cells until myofiber 
debris get cleared and myofibers re-establishes (Bentzinger, Wang, Dumont, & RUDNICKI, 
2013). Along with the deposition of the ECM proteins, one of the mesenchymal stromal cells, 
fibroblast adipogenic progenitor cells expand upon injury and secretes IL-6 for promoting the 
myogenic differentiation (Joe et al., 2010).  
As a result, more than 100 myofibers with small fiber diameters differentiated to fill 
the void gap for a month during the recovery phase. The non-treated groups (saline control and 
NDCell) demonstrated impeded reparative myogenesis (Figure 22A), resulting in significantly 
smaller average fiber sizes compared with the treated groups (DCell and hSkM). Nonetheless, 
owing to the expansion of the host’s muscle stem cells, the total fiber area of the non-treated 
groups comparable to the intact muscle (Figure 22B and Table 3). These trends were in line 
with the accumulation of excessive ECM protein (mostly collagen) and visualized by 
consecutive slides stained with H&E and Sirius red (Figure 22C); the less fibrotic scar was 
formed for the treated groups, while more collagen deposition was observed from the non-   
































































































































































































Figure 22. Morphometric evalution of the implanted cells in notexin-induced muscle injury 
model. H&E-stained TA muscle sections with the established notexin-induced muscle injury 
model (1 day) and the injury sites after a month compared to its saline control (A). Quantitative 
analyses based on the H&E-stained TA muscles, including the total number of fibers, total fiber 
area computed by Image J, the average fiber size — calculated from dividing the fiber area with 
the fiber number — and the % regenerated fibers. Control for the one day post injury was used 
as an intact muscle while control for one month post injury, saline control was used. All data 
are represented as means ± standard deviations. ** denotes p < 0.01, and *** denotes p < 0.001 
compared to control of each time point, and +++ denotes p < 0.001 compared to NDCell group 
(B). Consecutive H&E- and Sirius red-stained TA muscle images (200X) a month after injury. 
All scale bar represents 100 μm (C). Average percent fibrosis calculated from different treatment 
groups compared to the control (saline) group after a month of injury (D).  





Table 3. Summary of quantified morphometric evaluations of the regeneration of 
notexin-injured muscle. All data are represented as means ± standard deviations. ** denotes p 
< 0.01, and *** denotes p < 0.001 compared to control of each time point, and +++ denotes p < 
0.001 compared to NDCell group. 
Experimenta
l endpoint Groups 
Fiber 
Number 









Control 78 ± 11 83924 ± 1778 1098 ± 147 0 ± 1 
Notexin 57 ± 8 13709 ± 6247*** 256 ± 17*** 1 ± 1 
4 weeks 
(Notexin) 
Control 159 ± 33 78725 ± 7506 512 ± 98 50 ± 10 
NDCell 166 ± 21 78796 ± 7633 501 ± 108 55 ± 13 
DCell 108 ± 13++ 86235 ± 2281 850 ± 81**/+++ 54 ± 6 





Figure 23. Pathohistological analyses for dox having no therapeutic effect on saline controls. 
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treated groups. Another therapeutical aspect to note was the increase in average muscle moist 
weight for both control and treatment groups compared with the 2-week intact muscle model. 
This illustrates the enhanced muscle regeneration after 2 more weeks of recovery 
corresponding to the muscle weight of control (saline) without dox, NDCell, and DCell to 
39.34 ± 1.93, 42.32 ± 1.63, and 37.94 ± 6.68 mg, respectively.  
Quantitative analysis of %fibrosis also supported the delayed repair of muscle injury 
and necrotic tissue formation of non-treated groups, while both treated groups indicated 
significantly less %fibrosis compared to the non-treated groups (Figure 22D). For having the 
highest %fibrosis, the saline control group was further examined to evaluate the effect of dox 
administration to the host. As shown from Figure 23, similar inflammatory responses (e.g., 
necrotic tissue formation and collagen deposition) and the slow recovery of the affected sites 
were observed from both control groups, irrespective of the addition of dox. Muscle moist 
weight data were in line with the insignificant effect of dox addition on muscle phenotypes; 
the muscle moist weight of the saline control in the absence and presence of dox were measured 
as 39.34 ± 1.93 and 40.93 ± 6.17 mg, respectively.  
 
3.3.7.2. Immunocytochemistry analysis for cryosectioned-muscle tissues 
The immunohistochemistry results also demonstrated that the transplanted cells contributed to 
the stem cell niche by fusing to the damaged host muscle fibers and contributing to their 
recovery (Figure 24). iSkMs expressed both hNu for being human origin cells as well as FLAG 
for being transduced with the VdC9BV construct. Therefore, both markers were co-localized 
with DAPI at the nucleus for the DCell group, committed to myogenic lineage and 
transdifferentiated to iSkMs. Conversely, cells without dox (NDCell group) expressed hNu, 
but lacked FLAG expression as they were not committed to skeletal myocytes while 
maintaining the signatures of the donor cells. Therefore, injected NDCells were located near   















Figure 24. Transverse cryosections of the cell-transplanted TA muscle indicating the 
engraftment of iSkM in situ after a month of injury. Scale bar indicates 20 μm.  
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the quiescent muscle satellite cells beneath the basal lamina, indicating no partaking in the 
regeneration of myofibers. Unlike inactive HNu+ NDCells, surrounding centronucleated 
myofibers with muscle satellite cells have higher reparative contribution rate for injury 
restoration.  
Muscle satellite cells (skeletal myoblasts) are also known as muscle stem cells. In a 
typical matured myofiber environment, they stay quiescence beneath the myofiber’s basal 
lamina (Schmalbruch & Lewis, 2000). Such cells self-renews in asymmetrical cell division and 
provides heterogeneous cell types in the satellite cell niche: a mixture of committed myogenic 
progenies and uncommitted cells, which remains as mother cells (Bentzinger et al., 2013). 
Between these two groups, only actively proliferating myoblasts express MYOD1, which 
mimics the phenotypes of our committed (DCell). The reason for the total fiber area and the 
%regenerated fibers to be insignificant across the groups was also due to the expansion of the 
host’s myoblasts, which led the active formation of newly differentiated centronucleated 
myofibers. In order to thwart the faster regeneration rate of the host’s myoblasts, few studies 
utilized radiation to ablate them. Exposing mice with 18 Gy γ-irradiation before cell injection 
formed a significantly higher number of myofibers of implanted cell origin (Gross, Bou-
Gharios, & Morgan, 1999). However, for our study, as the radiation facility was inaccessible, 
it was not feasible to regulate the differentiation rate of the murine myoblasts and better control 
the therapeutic effects of the control groups (saline control and NDCell). For proper 
assessment, γ-irradiated genetically modified animal models, such as dystrophin-lacking mdx 
model, should be used for future experiments. 
 
3.3.7.3. Assessing the contribution of the transplanted cells on 
neoangiogenesis   
Efficiency is a known limitation of direct reprogramming, owing to the retention of the donor 
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cell’s epigenetic memory (K. Kim et al., 2010b; Vierbuchen & Wernig, 2012). Therefore, we 
speculated that some portion of the DCell group might have remained as EPCs, even with the 
administration of dox. Since EPCs are known to play a regulated role in neovascularization —
a process involving proliferation, migration, and adhesion to remodel pre-existing vasculatures 
(Kamei, Atesok, & Ochi, 2017)—, we extended our goal to assess the contributions of non-
reprogrammed cells to host neoangiogenesis during the regeneration process by CD31+ and 
vWF+ expression patterns. From the immunostained-tissue sections, differences were apparent 
between the negative control and the DCell group: CD31 was expressed significantly more 
from the DCell group, demonstrating the enhanced vascularization at the environs of the 
injured tissue compared to control (Figure 25). As shown in Figure 26, the ratio (A) and the 
average number per area of CD31+ capillaries and vWF+ EPCs (B) were also quantified for 
comparison. From both analyses, more capillaries were formed by DCell group compared with 
the control group and as EPC plays a crucial role in angiogenesis, a higher density of EPC 
correlated with the higher number of local capillaries. However, for the global contribution of 
transplanted cells on the host microenvironment, the relative gene expression pattern should 
be analyzed for the future studies. 
 
  


















Figure 26. Quantified ratio and average number of CD31+capillaries and vWF+ angiogenic 
endothelial cells after 1 month post-injury for control and DCell groups. ** indicates p < 0.01 
Figure 25. Contribution of iSkMs on local neoangiogenesis compared to saline control at the 
muscle injury site. Scale bars indicate 100 and 50 μm for the DAPI/CD31/vWF and merged 
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Chapter 4. Enhancing the neural cell fate 
commitment by deploying biochemical cues and 
substrate-mediated electrophysical cues 
 
 
4.1.  Rationale and Significance 
 
In this section, we focus on substrate-mediated microenvironmental stimuli combined with 
biochemical cues, which can epigenetically modulate cell fate by activating the intricate 
mechanotransduction pathways of cells. We hypothesized that the combination of graphene-
based substrates with the biochemical factors would assist the promotion of directed 
differentiation and transdifferentiation of neuronal stem/progenitor cells and somatic cells to 
neuronal lineages, respectively. 
Surface characteristics of the substrates can help govern cell fate and their behaviors. 
Researchers have engineered the substrate-mediated cues for guiding the cell fate by 
manipulating the substrate rigidity, roughness, topography, and other biophysical features. For 
example, engineering the topography of substrates (both nano- and micro-scales) can offer 
forced confinement for cells to artificially align themselves on a patterned/aligned substrates, 
which have been documented to facilitate the directed differentiation (human MSCs to neurons 
(Yim et al., 2007) and adult heart-derived progenitor cells to cardiomyocytes (Morez et al., 
2015)), reprogramming (MEF and human dermal fibroblasts to iPSCs (Downing et al., 2013)), 
and transdifferentiation (somatic cells to various neuronal lineages (Kulangara et al., 2014; 
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Yoo et al., 2015)).  
For the substrate, we chose an electroactive graphene-based substrate with aligned 
micropatterns to evaluate whether it guides subtype neuronal differentiation and 
transdifferentiation processes. Graphene-based materials have exhibited excellent 
biocompatibility and capabilities in facilitating cell adhesion, proliferation, neural 
differentiation, and axonal outgrowth of MSCs, NSCs, and iPSCs. It is known to support the 
growth of neuronal lineages for its robust surface chemistry and excellent mechanical 
properties, but the molecular mechanism of how graphene supports the cell-cell or cell-matrix 
interactions is not yet elucidated. Because of its hydrophobicity, pretreatment with oxygen 
plasma treatment is necessary for ECM protein coatings, but the bulk property of conductivity 
is not affected by the protein coating. 
The rationale behind using highly conductive graphene originates from the notion that 
electrical stimulation can facilitate NSC/PCs migration to target sites and differentiate them 
into neurons ex vivo (Huang, Li, Chen, Zhou, & Tan, 2015). Moreover, in pre-clinical studies, 
the potency of electrical stimulation on enhancing neurogenesis has been documented. 
The addition of eight small molecules allows rapid, transient, efficient, economic, and finely-
tuned regulation of cell fate change. As we use epigenetic modulators (inhibitors and activators 
of key cellular regulation pathways), the microenvironment exposed to cells is more permissive 
to neurogenesis and survival of NS/PCs. Eliminating the usage of viral vectors and 
transcription factors, and any associated risks for insertional mutagenesis are avoided upon 
using soluble factors. This provides a potent means of inducing neurons from easily accessible 
and robust cell sources, such as fibroblasts. For our purpose, as graphene is non-transparent, to 
track their morphology, fetal human dermal fibroblasts expressing GFP (fHDF-GFP) was used. 
As a first demonstration, our work illustrates the graphene-based substrate with high 
conductivity (> 650 S/m) can promote the human neuronal lineage from varying cell sources: 
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NSCs, NPCs, and fHDF-GFP. In other studies, instead of graphene, graphene derivatives 
(graphene oxide or reduced graphene oxide) are utilized to replace for graphene’s strong 
hydrophobicity. This completely removes or reduces graphene’s natural feature of the highly 
conductive substrate, thereby losing the rationale behind using the electroactive substrate. 
Along with its high conductivity, the graphene substrate is fabricated from a graphene paint, 
mixed with a medical-grade poly-lactide-co-glycolide (PLG) at the ratio of 60:40 (in Volume 
%) mixed in organic solvents to make them into a paste. The viscosity is maintained for 
enabling it to push through a piston for 3D printing. Such a method of substrate fabrication 
allows rapid, simple, and versatile means for fabricating any polymer-based composites. 
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4.2. Methods 
 
4.2.1. Fabrication and surface modifications of the graphene-based 
substrates 
To fabricate the graphene:PLG composites, established method was used as previously 
mentioned in Jakus et al. (Jakus et al., 2015). Briefly, 60 % graphene inks in volume were 
synthesized by thoroughly mixing PLG copolymer (85:15; Boehringer Ingelheim), graphene 
powder (38 atomic layers thick, 520 μm long and wide; Graphene Laboratories Inc), and a 
10:2:1 by mass mixture of DCM (Sigma), ethylene glycol butyl ether (Sigma), and dibutyl 
phthalate (Sigma), where 0.6 g of dibutyl phthalate was added for every 2.2 g (1 cm3) of 
graphene. Graphene comprised 60 % of the solid additions in volume, while PLG comprised 
the remaining 40 % in volume. Inks were allowed to thicken to a viscosity of 3035 Pa.s., as 
determined through the use of a Brookfield DV-E rotational shear viscometer, through 
evaporation under ambient conditions before 3D printing. Pure PLG inks were also prepared 
using the same protocol. 
The grooved structures of graphene:PLG composites and PLG were fabricated using a 
3D BioPlotter (EnvisionTEC GmbH). The 200 μm diameter polyethylene tips (Nordson EFD) 
was used throughout the study. Both PLG inks and the graphene-PLG inks were 3D-printed 
onto a smooth, polytetrafluoroethylene-coated substrate. The speed of the XY motion ranged 
from 10 to 45 mm/s based on the features of the printed objects. They could be directly removed 
from the substrate and handled immediately after printing. All ink syntheses and printing were 
performed at RT. The grooved substrate was printed using 200 μm diameter polyethylene tips 
and approximately 180 μm spacing between fibers. The printed grooved substrates were all 
kept at 4 °C till future use to maintain their features. 
Two types of graphene:PLG mixed substrates were used for the study along with the 
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conventionally used negative control as a glass disc. Both were produced and generously 
provided by our collaborators, Prof. Shah and Dr. Jakus, from the University of Chicago and 
Dimension Inx LLC, respectively as published (Jakus et al., 2015): 1) graphene:PLG-cast sheet 
and 2) monolayer 3D-printed grooved graphene:PLG substrate (3DG), fabricated with a 
diameter of 250 μm extrusion tip, thereby having the aligned patterns with approximately 200 
μm widths. All tested substrates were punched with two different sizes (8 mm and 12 mm) of 
biopsy punches, rinsed with 70 % ethanol for at least an hour on a rocker and rinsed with 
autoclaved distilled water for three times. After completely drying the substrates, they were 
placed in the oxygen plasma cleanser (Harrick Plasma Inc.) for conferring hydrophilicity. Upon 
functionalizing the surface with oxygen for 1 min at a ‘high’ setting, substrates were sterilized 
under UV exposure for 20 mins and subsequently coated with 0.01 % poly-D-lysine (PDL; 
Sigma, P7405) overnight at 4 °C. 
On the next day, following the original protocols, various types of protein coatings were 
utilized for the directed differentiation to MN and DA neurons and direct reprogramming to 
induced pan-neurons. For MN differentiation, substrates were coated with LM (20 ng/μl; 
Millipore Sigma, L2020) overnight at 4 °C. For DA neuron differentiation, substrates were 
coated instead with 15 µg/ml poly-L-ornithine (PLO) overnight at 4°C and on the following 
day, 5 µg/ml of FN (Sigma, F2006) and 4 µg/ml of LM were mixed and diluted with DPBS to 
be coated overnight at 4°C. For direct conversion to induced neurons, oxygen plasma-treated 
substrates were coated with 0.1 % porcine gelatin (Sigma) for at least an hour at 37 °C before 
seeding fHDF-GFP. For preventing the discrepancy of cell seeding number, cells were plated 
at the center of each substrate at least three hours before media was added to provide them 
enough time to attach to the coated culture platforms. 
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4.2.2. Characterization of the graphene-based substrates  
Both graphene:PLG composites were prepared for the FE-SEM analysis by sputter 
coating the samples with platinum and micrographs were captured at the magnification of 300X 
using Zeiss Sigma 500. For visualizing the electric flow through the graphene:PLG composite, 
the apparatus was set up by contacting/disconnecting the sample with a wire in series with a 
green LED probe. The XRD patterns were measured with Ultima IV (Rigaku) in the diffraction 
angle (2q),  ranging from 5 to 60°, at a rate of 2°/min with an interval step-width of 0.02° using 
Cu-Ka radiation at 40 kV and 40 mA. The conductivity was measured in triplicates with a 
conventional method using a 4-point probe from NWU collaborators. The wettability of each 
substrate was measured by the contact angle between a water droplet and the graphene interface 
with and without the oxygen plasma treatment. The angles were measured from triplicates of 
each sample using Image J. 
 
4.2.3. Cell maintenance and media compositions 
Two iPSC-derived NSCs and NPCs were used for specific neuronal (MN and DA neurons, 
respectively) differentiation and for pan-neuronal direct reprogramming, fHDF-GFP was used.  
The iPSC-derived NSCs (MTI-GlobalStem, GSC-4311) were proliferated on 1:200 
diluted Geltrex (ThermoFisher Scientific, A1413302)-coated substrates with the NSC growth 
medium: Knockout DMEM/F12 (ThermoFisher Scientific, 12660-012), N2 (ThermoFisher 
Scientific, 17502048), bFGF (20 ng/ml; ThermoFisher Scientific, PHG0264), EGF (20 ng/ml; 
ThermoFisher Scientific, PHG0311), NEAA, and P/S. For the experiment, all NSCs were used 
under passage 6. The MN priming media was composed of: DMEM/F12 (ThermoFisher 
Scientific, 11330-033), supplemented with 15mM HEPES, GlutaMAX, N2, bFGF (10 ng/ml), 
heparin (2.5 μg/ml), LM (1 μg/ml), and niclosamide (0.125 μM); and the maturation media was 
composed of DMEM/F12, supplemented with 15 mM HEPES, GlutaMAX, and B27 
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(ThermoFisher Scientific, 17504044).  
Professor Bin Xu’s lab from the Columbia University kindly provided the iPSC-derived 
NPCs following the induction process of iPSCs to NPCs using the optimized dual SMAD-
inhibition-based floor plate induction protocol (Kriks et al., 2011; Tomishima, 2012). NPCs 
were proliferated on the Matrigel-coated (1:100 diluted with a basal media) substrates with the 
proliferation media composed of DMEM/F12 (ThermoFisher Scientific, 11330-033) and 
neurobasal media (NBA; ThermoFisher Scientific, 21103-049) at 1:1, supplemented with N2, 
B27 (ThermoFisher Scientific, 12587010), NEAA, GlutaMAX, b-mercaptoethanol, and P/S. 
DA neuron differentiation media was based on neurobasal media, supplemented with 
GlutaMAX, B27, P/S, BDNF (20 ng/ml, Peprotech, 450-02B-10), ascorbic acid (200 μM), 
GDNF (20 ng/ml, Peprotech, 450-10B-10), cyclic adenosine monophosphate (cAMP; 500 μM; 
Millipore Sigma, 28745), TGF-b3 (1 ng/ml, Peprotech), DAPT (10 μM; R&D Systems, 
2634/10), and CHIR99021 (3 μM; only added for the first 3 days of the induction process).  
Upon passaging both NSCs and NPCs, Y-27632 (10 μM) was added for the first 24 hrs to 
improve the single cell viability.  
For direct lineage reprogramming to induced neurons (iNs), primary fHDF-GFP (P9) 
was kindly provided by Prof. Shim’s group at DKU. These cells were maintained with DMEM-
HG (ThermoFisher Scientific, 11995040), supplemented with 10% FBS, GlutaMAX, P/S, and 
b-mercaptoethanol. Additionally, following small molecule cocktails were used for this study 
as previously established in Hu et al. (Hu et al., 2015): Valproic acid (VPA; 0.5 mM; 
Calbiochem, 676380), CHIR99021 (3 μM; BioVision, 1677), Repsox (1 μM; BioVision, 1894), 
Forskolin (10 μM; Sigma, 3917), SP600125 (10 μM; Sigma, S5567), Gö 6983 (5 μM; Sigma, 
G1918), Y-27632 (5 μM), and Dorsormorphin (1 μM; Cayman, 11967). For abbreviation, only 
the first letter of each chemical name was used for denoting the chemical cocktails. Neuronal 
induction medium (NIM) was composed of a mixture of VCRFSGY in DMEM/F12 
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(ThermoFisher Scientific, 11330-032) and NBA at 1:1, supplemented with N2, B27 
(ThermoFisher Scientific, 17504044), cAMP (100 μM), bFGF (20 ng/ml), and P/S. Neuronal 
maturation medium (NMM) was composed of CFD in DMEM/F12:Neurobasal media (1:1), 
N2, B27, cAMP (100 μM), bFGF (20 ng/ml), BDNF (20 ng/ml), GDNF (20 ng/ml), NT3 (20 
ng/ml; Peprotech, 450-03-10) and P/S. All neural stem and progenitor cells were passaged with 
Accutase and used up to P6 for all the experiments.  
 
4.2.4. Verification of cell viability and fate transitions of donor cells on 
in vitro culture platforms  
The CCK-8 cell viability test (Dojindo) was conducted at the dilution of 1:10 with media to 
check the proliferation of NS/PCs on various substrates after 2 days. Upon 3 hours of 
incubating the live cells with CCK-8 dye at 37 °C, the plate reader was used to measuring the 
intensity of the formazan dye.  
 To check the cell morphology on graphene-based or PLG-based nontransparent 
substrates, differentiated MNs were fixed after 11 days and added with cold 2.5% 
glutaraldehyde for 120 mins. Then, it was post-fixed in 2% osmium tetroxide (EMS) for 60 
mins and dehydrated using gradually increased concentrations of ethanol. Specimens were then 
dried under the chemical hood for overnight and sputter-coated with 5 nm gold/palladium. 
Cells were examined by SEM (Sigma VP, Zeiss) at 20 kV accelerating voltage. 
 
4.2.5. Generation of terminally differentiated MNs and DA neurons 
and chemically iNs 
For each differentiation or transdifferentiation protocol, lineage-specific chemically defined 
conditions with varying cell density were used to guide the cell fate to their target lineages, as 
depicted in Figure 29. 
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To yield MN differentiation, 100,000 to 150,000 cells were seeded for 12 mm-sized 
substrates. After 2-3 days of stabilization on the substrate, MN priming media was given for 4 
days, followed by the maturation media for 2-9 days until analysis. 
For obtaining DA neurons from iPSC-derived NPC cells, they were passaged from day 
11 and seeded at the density of 150,000 to 200,000 cells per 12 mm-sized substrates. NPCs 
were replenished every other day with DA neuron differentiation media for at least two weeks 
until further analysis. 
Initially, fHDF-GFP was seeded at the density of 12,000 cells per 12 mm-sized substrates 
and chemically iNs were generated by feeding fHDF-GFP with NIM for 8 days and 
replenishing it every 4 days. Then, NMM was given for the next two weeks and half-changed 
every other day until further analysis. 
 
4.2.6. Assessment of differentiation and reprogramming efficiency 
4.2.6.1. Confirming target neuronal signature by immunofluorescent staining 
and qRT-PCR  
All staining procedure (8% PFA) was processed as mentioned above. The primary antibodies 
used here were anti-mouse Tuj1 (Covance, MMS-435P), anti-rabbit HB9 (Abcam, ab92606), 
and anti-mouse TH (Chemicon, MAB318) and anti-chicken MAP2 (Abcam, ab5392). The 
same secondary antibodies were used as mentioned in 3.2.3.3. Images were taken by Nikon A1 
confocal laser microscope system using the NIS-Elements. Quantitative image analyses were 
performed in 3 random view fields from the image using the Neurite Tracer extension from 
Image J.  
 For isolating total RNA, cells were detached from each (12 mm-sized) substrate by 
incubating 300 μl of Accumax for 30 mins followed by addition of 300 μl of collagenase IV 
for 30 mins. Detached cells were collected after centrifugation at 1000 rpm for 5 mins. Upon 
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aspirating the supernatant, 300 μl TRIzol (ThermoFisher Scientific) was added to the cell 
pellets and the remainder of the substrate for extracting total RNA using the Quick-RNA 
Microprep Kit (Zymo Research). Subsequently, an equal volume of 70 % ethanol was added 
and thoroughly mixed loading the mixture to the column and follow the manufacturer’s 
manual. The cDNA was synthesized from 500 ng of extracted RNA using the iScript cDNA 
synthesis kit (BioRad). As mentioned in 3.2.4.1, qRT-PCR was conducted with the primers 
listed in  
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Forward: GTA ACC CGT TGA ACC CCA TT 
Reverse: CCA TCC AAT CGG TAG TAG CG 
MAP2 
Forward: TTG GTG CCG AGT GAG AAG AA 













ChAT Forward: ACT GGG TGT CTG AGT ACT GG Reverse: TTG GAA GCC ATT TTG ACT AT 
TBR2 Forward: CACCGCCACCAAACTGAGAT Reverse: CGAACACATTGTAGTGGGCAG 
GBX2 Forward: AAAGAGGGCTCGCTGCTC Reverse: ATCGCTCTCCAGCGAGAA 
OCT4 Forward: GTGGAGGAAGCTGACAACAA Reverse: ATTCTCCAGGTTGCCTCTCA 
NANOG Forward: AAGGTCCCGGTCAAGAAACAG Reverse: CTTCTGCGTCACACCATTGC 
OTX2 Forward: CAT GCA GAG GTC CTA TCC CAT Reverse: AAG CTG GGG ACT GAT TGA GAT 
FOXA2 Forward: GGA GCA GCT ACT ATG CAG AGC Reverse: CGT GTT CAT GCC GTT CAT CC 
LMX1A Forward: ACG TCC GAG AAC CAT CTT GAC Reverse: CAC CAC CGT TTG TCT GAG C 
NURR1 Forward: ACC ACT CTT CGG GAG AAT ACA Reverse: GGC ATT TGG TAC AAG CAA GGT 
TH Forward: GGG CTG TGT AAG CAG AAC G Reverse: AAG GCC CGA ATC TCA GGC T 
PITX3 Forward: CCT ACG AGG AGG TGT ACC CC Reverse: CCC ACG TTG ACC GAG TTG A 
DAT Forward: TTT CTC CTG TCC GTC ATT GGC Reverse: AGC CCA CAC CTT TCA GTA TGG 
EN1 Forward: GAG CGC AGG GCA CCA AAT A Reverse: AAT AAC GTG TGC AGT ACA CCC 
GIRK2 Forward: CAC ATC AGC CGA GAT CGG AC Reverse: GGT AGC GAT AGG TCT CCC TCA 
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4.2.6.2. Quantification of neurite directionality and elongation by ImageJ 
To quantify the alignment of the chemically induced neurons across each substrate, their 
directionalities were measured. Briefly, the fluorescent images of the fHDF-GFP, taken at the 
magnification of 4X, were used for each time point at Days 4, 8, 12, 16, and 20. Three or four 
microscopic fields around the center were used for analysis. Each image was converted to 8-
bit greyscale and analysis was conducted by running the “Directionality” plugin (from ImageJ) 
using the Fourier component analysis (Liu, 1991) with the bin size of 90. Angle measurement 
was defaulted to measure in the direction from the positive x-axis to the positive y-axis. 
Collected massive data was plotted in a scatter plot in GraphPad Prism 6.  
 Total neurite length and average neurite length per cell were measured using 
“Morphology” and “Neurite tracer” plugins from Image J. This plugin has an excellent 
interface to perform neurite length measurements. Briefly, a black background will be saved 
in a working directory/folder to offset the background. As the neurites from the Tuj1+ cells and 
from the DAPI+ nuclei were measured, all the split channeled images were re-labeled based on 
the designed macro: “beta3Tublin_” and “DAPI_,” respectively. Upon changing the name, all 
the added raw files were added to the working directory and the threshold size of the nuclei 
was set to avoid counting the artifacts throughout the analysis. After setting up the lower and 
upper threshold values, the analysis started and the system automatically found the neuronal 
cells extending neurites in various directions for tracing, which was later summed up for the 
total count of  cells for quantifications. Post-analysis was conducted using Microsoft Excel.  
 
4.2.7. Validation of cell functionality  
4.2.7.1. Evaluating the functionality of the induced neurons via 
electrophysiology   
In order to verify our differentiation protocol, the functionality of the motor neurons was 
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evaluated by co-culturing them with the primary mouse astrocytes treated with cytosine 
arabinoside (Ara-C). Ara-C was used to prevent microglial contamination and the proliferation 
of astroglial cells. For this procedure, the P2 mouse astrocytes were kindly provided by Dr. 
Saera Song from Dr. Goldstein’s lab. First, the 100,000 primary mouse astrocytes were seeded 
on a gelatin-coated 15 mm discs (as mentioned in 4.2.1.) and fed with the same DMEM-HG 
media condition as used for culturing fHDF-GFP cells (as mentioned in 4.2.2.) in a 12-well 
plate. Then, 10 µM of Ara-C was added to each well and replaced with fresh media on the next 
day. After cells were differentiated for 51 days, they were detached using the Accutase + 
Collagenase IV method (as described in 4.2.6.) and  30,000 cells were seeded at the center of 
the astrocyte-seeded discs and cultured for 2 more additional weeks with the same 
differentiation medium. For the first day of co-culture, Rock inhibitor was added.  
The electrophysiology test was conducted by Dr. Damian Williams from Dr. Boland’s lab. 
The membrane potential recordings were performed using a Multiclamp 700B amplifier and a 
Digidata 1550 digital-to-analog converter (both from the Molecular Devices). Signals were 
filtered at 10 kHz with a low pass Bessell filter and digitized at a 10-kHz sample rate. The 
patch pipettes were constructed with a P-97 pipette puller (Sutter Instruments) using 1.5 mm 
outer diameter and 1.28 mm inner diameter filamented capillary glass (World Precision 
Instruments). The pipette resistance was 2 to 5 MΩ when filled with its recording solution. The 
external one was made of 145 mM NaCl, 5 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM 
CaCl2, and 2 mM MgCl2. The pH was maintained at 7.3 using NaOH and the osmolality was 
set to 325 mOsm using sucrose. The pipette solution consisted 130 mM CH3KO3S, 10 mM 
CH3NaO3S, 10 mM EGTA, 10 mM HEPES, 5 mM MgATP, 1 mM CaCl2, and 0.5 mM 
Na2GTP. The same pH was maintained as the external solution, but the osmolality was adjusted 
to 305 mOsm.  
The experiments were all performed at RT and during recordings, current was injected to 
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hold the cells at approximately -60 mV. The liquid junction potential across the pipette and 
external solutions was calculated empirically and the correction was applied before the 
experiment. The resting membrane potential (RMP) was measured immediately following the 
establishment of the whole-cell patching apparatus. Membrane resistance and capacitance were 
both calculated from the changes in membrane potential in response to hyperpolarizing current 
injection step, which increased incrementally by -4 pA, for 1 sec. Action potentials (APs) were 
evoked using 1-sec duration depolarizing current steps that increased incrementally by 4 pA. 
An AP was defined as a transient depolarization of the membrane, which had a minimum rise 
rate of more than 10 mV/ms and reached a peak amplitude of more than 0 mV. AP 
characteristics were measured from the first AP at rheobase. The AP threshold was measured 
at the point where the voltage increases at a rate higher than 10 ms/mV. The AP duration was 
calculated from the full width at the half-maximum voltage and the amplitude was measured 
from the threshold to the maximum potentials. The maximum number of AP was measured 
from a 1 sec current step. The amplitude of the step depended on the individual cell. 
Quantification was carried out using customized scripts for Igor Pro version 6 (Wavemetrics) 
and R version 3 (www.R-project.org). The electrophysiology results were based on randomly 
selected 19 cells from the control group.  
 
4.2.7.2. Assessing the functionality of mDA neurons by dopamine release 
After 35 days of DA neuron induction, to quantify the extracellular dopamine concentration 
from the media, two sets of differentiated cells were incubated with and without 300 μl of L-
DOPA (reconstituted in 0.1 M of HCl and diluted in DMEM/F-12 medium supplied with N2 
and B27) for 45 mins in the dark. For the untreated group, as a control, same basal media was 
added with equal volume as the L-DOPA treated group. After incubating for 45 mins, the media 
was aspirated, each well was rinsed with PBS twice, and incubated with 100 μl of Tyrode’s 
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salt buffer with 40 mM KCl for 5 mins. Then, 95 μl of the sample was collected and mixed 
with 0.2 M perchloric acid (Sigma) in a 1:1 ratio to protect the oxidization of released dopamine 
and stored at -80 °C for later use.  
 To measure the intracellular dopamine release, 50 μl of fresh Tyrode’s salt buffer with 
40 mM KCl was added to each well. Then, each well was triturated with the pipette and 
transferred to a tube. Additionally, 50 μl of fresh Tyrode’s salt buffer was added to wash the 
well and transferred to a tube. The collected supernatant was divided in half: 1) from the first 
half of the sample, an equal volume of 70 μl of 0.2 M of perchloric acid was added, and 2) 
from the other half, 20 μl of the sample was collected for conducting the Picogreen DNA 
detection assay to normalize the dopamine concentration by the DNA content. To remove the 
cell debris, 1) sample was incubated on ice for 10 mins and spun down (at 10,000 g) for 5 mins 
at 4 °C. Then, the supernatant was collected and stored at -80 °C for later use. Both samples 
were stored for measuring extracellular and intracellular dopamine release utilizing the 
reversed-phase HPLC with electrochemical detection within 2 weeks of the collection, as 
described previously under the blinded condition (Steinbeck et al., 2015). All the experiments 
were conducted by Moshe Wilner at Prof. Eugene Mosharov’s lab.  
For visualizing cells on non-transparent graphene substrates, NSCs were transduced 
with pLV-hSyn-RFP (Addgene 22909), encoding lentivirus by following the established 
protocol (previously mentioned in Chapter 3.2.3.). For lentiviral production, HEK293T/17 
(ATCC, CRL-11268) was used. After testing the titer of the virus, the MOI test was conducted 
with and without protamine sulfate (4 μg/ml)  as polybrene (8 μg/ml) was too toxic for NSCs 
to survive. Different concentrations of MOI were tested and the expression level of DsRed was 
also quantified using the following primer pairs normalized to the values of 18s rRNA:  
• DsRed Forward: AGGACGTCATCAAGGAGTTC 
• DsRed Reverse: TCTGGGTGCCCTCGTAG 
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4.2.8. Statistical Analysis 
For statistics, all the values were presented as means ± stdev unless otherwise mentioned. For 
comparison, one-way or two-way ANOVA was used for comparing multiple groups with the 
post hoc analysis of Tukey’s or Sidak’s multiple comparison tests, respectively, using 
GraphPad Prism 6. Statistical significance was denoted as: * for p < 0.05, ** or ++ for p < 
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4.3. Results and Discussion 
4.3.1. Directed differentiation of iPSC-derived NS/PCs to MNs and DA 
neurons using physical and biochemical factors 
4.3.1.1. Physical and biochemical factors to tailor cell fate to specific neuronal 
subtypes 
To evaluate the effect of cell fate determination, highly electroactive substrates with two 
different features were fabricated using the 3D-printed method, as briefly illustrated in Figure 
27A. This method allows economic, easy, and rapid fabrication of substrates at RT with 
varying patterns and materials. For mimicking the native features of neurons, two different 
substrates were utilized: 1) graphene:PLG cast sheet and 2) grooved 3DG with aligned patterns. 
For graphene’s hydrophobic nature, oxygen plasma treatment was necessary prior to ECM 
protein-coatings for conferring hydrophilicity. ECM protein-coatings were utilized to mimic 
the niche-like conditions and support the cell’s viability and subsequent directed differentiation 
process for both NS/PCs. Measuring the contact angles before and after oxygen plasma 
treatment confirmed the decrease in wettability (Figure 27B and Figure 27C) and subsequent 
ECM protein-coatings with PDL-LM and PLO-LM/FN (Figure 27D) were verified by LM 
staining for both sheet and 3DG. As the bulk property of graphene does not alter by surface 
modification with ECM proteins, the electroactive features were maintained even after the 
coating. Surface conductivity did not significantly change for the non-coated, LM-coated, and 
PDL-LM coated graphene substrates and maintained around 700 S/m (Figure 27E).  
The physical and electroactive features of graphene:PLG sheet and 3DG substrates 
were verified by the FE-SEM, open/closed circuit test, and their XRD patterns (Figure 28). For 
confining the cell features to elongated morphology, aligned 3DG was utilized, as shown in 
Figure 28A. Unlike 3DG, graphene:PLG sheet portrays the random organization of graphene 
flakes on the cast sheet. However, as both substrates contain electroactive graphene flakes,  
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Figure 27. Fabrication and ECM protein coating of graphene substrates. Two different 
Graphene:PLG composites were used for the study: graphene:PLG-ink cast sheet, and 3D-
printed 3DG sheet (A). Prior to protein coating, graphene:PLG composites were exposed to 
oxygen plasma to confer hydrophilicity (B). The contact angles before and after the oxygen 
plasma treatment were compared for both substrates (C). PDL-LM and PLO-LM/FN coatings 
were treated and quantified for the LM intensity compared to glass substrate (D). Change in 
substrate conductivity was measured before and after the LM or PDL-LM coating to confirm 
the change is not significant (E). LAM denotes LM. n = 3 for all the studies.    
Figure 28. Characterization of graphene:PLG composites. FE-SEM analysis (top) to 
verify the patterns on each substrate and open/close circuit analysis to test the conductivity 
of the substrates with LED (bottom)(A). XRD patterns recorded for both substrates (B).   
B A 
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the LED light turned on when the wires were connected through the graphene composites in a 
closed circuit, indicating their high electric conductivity. Besides, the XRD patterns of both 
graphene composites were similarly indexed to the characteristic diffraction peaks of graphite, 
based on the Joint Committee on Powder Diffraction Standards card No. 12-0212, where 
prominent peaks are visible at 2θ = 26.43 and 54.51°. No additional noticeable diffraction 
patterns were observed, indicating the high purity of the fabricated graphene-based substrates.  
 With these culture platforms, we hypothesized that substrate-mediated biophysical cues 
along with soluble extrinsic factors could guide the uncommitted iPSC-derived NSCs and 
NPCs to target neuronal (MNs and DA neurons) subtypes, respectively (Figure 29). Preparation 
and formulation of biochemical cocktails and differentiation protocols were adapted 
accordingly from Jordan et al., 2009, Natarajan et al., 2014, and Kriks et al., 2011.  
 Both donor cells for MN and DA neurons started from iPSC donor cells. For increasing 
the motor neuron specification, iPSC-derived NSCs were primed for 4 days with FGF, heparin, 
LM, and niclosamide (STAT3 inhibitor). The addition of niclosamide is known to block the 
activation of STAT3, thereby decreasing the astrocyte marker and increasing the MN-specific 
markers (Natarajan et al., 2014).  
After iPSCs were induced to NPCs, their genetic profile was identified to verify the 
plasticity/maturity level of NPCs, as shown in Figure 30. As the addition of biochemical factors 
was to obtain mDA neurons, instead of maintaining the pluripotent characters (OCT4 and 
NANOG), series of chemical cocktails upregulated the DA neuron-specific transcription 
factors compared to the control cells. This modified dual-SMAD inhibition (by exposing to 
LDN193189 and SB431542) protocol also led to the co-expression of FOXA2, the floor-plate 
marker, and LMX1A, the roof plate marker. Then, the treatment with purmorphamine and SHH 
is known to the downregulate FOXA2 and inhibits the expression of LMX1A. Upon the 
addition of CHIR99021 (GSK3 inhibitor), the WNT signal was activated and it upregulated   




























Figure 30. Relative gene expression level of the induced NPCs derived from iPSCs for a 
week compared to parental cells. Expression level was normalized with GAPDH. 
Abbreviations: FOXA2, Forkhead Box A2; LMX1A, LIM homeobox transcription factor 1 
alpha; TH, tyrosine hydroxylase; OTX2, Orthodenticle Homeobox 2; DAT, dopamine 
transporter; PITX3, Paired Like Homeodomain 3; PAX6, paired box protein 6; TBR2, T-Box 
Brain Protein 2; GBX2, Gastrulation Brain Homeobox 2; OCT4, octamer-binding 
transcription factor 4; NANOG, homeobox protein NANOG; TUBB3, neuron-specific class 
III beta-tubulin; MAP2, microtubule-associated protein 2.  
Figure 29. Soluble factors-mediated directed differentiation of iPSC-deirved NSCs to MNs 
(A) and iPSC-derived NPCs to DA neurons (B).  
A. MN differentiation  
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the anterior marker OTX2. 
 
4.3.1.2. Cell viability and changes in cell morphology on various substrates 
After fabricating the graphene:PLG composites and modulating the surface, the NS/PC 
viability and neural cell morphology were assessed using the CCK8 cell viability assay (Figure 
31) and various microscopy techniques (light and fluorescence microscopes and SEM; Figure 
32), respectively. After two days of cell seeding, no significant change in cell viability was 
observed for neither NSCs nor NPCs cultured on various culture platforms (Figure 31A). As 
graphene:PLG composites are non-transparent, the changes in cell morphology over time were 
observed for both directed differentiation to MN and DA neurons cultured on control TCPS 
substrates. As established from previous works, extrinsic factors led to a change in distinct cell 
morphology over time for both MN and DA neurons (Figure 31B).  
Unlike DA neurons, for MNs, as the directional growth is pivotal for migrating 
electrical signals and reestablishing the neighboring neuronal connections (Shin et al.,2003), 
its morphology on graphene:PLG composites was confirmed using the FE-SEM (Figure 32). 
After 2 weeks of exposure to soluble factors and electroactive substrates, more mature neurons 
with thicker neurites were formed on graphene:PLG composites compared to the control. 
Interestingly, on the 3DG substrate, a higher density of processes outgrew with sophisticated 
connectivity and it was more structured along the patterns of 3DG. In contrast, on the sheet and 
control substrates, immature neurons were randomly organized with membrane protrusions, 
such as lamellipodia and filopodia.  
For the non-electroactive substrate controls (PC and PA), cell viability was 
substantially lower, and a higher number of cell debris was observed compared to electroactive 
substrates. From the CCK8 assay, cell survival was verified for up to 2 days in the proliferation 
media. However, the long-term culture (2 weeks) of NSCs on the PLG-based substrates 
exhibited poor biocompatibility for MN differentiation and eliminated for further analyses.  























Figure 31. Cell viability and change in morphology for directing differentiation process 
for MN and DA neurons on various substrates. CCK-8 cell viability tested on different 
substrates over two days (A). Changes in cell morphology over time during the differentiation 
process on glass and TCPS for MN and DA neuron differentiation, respectively (B). Scale 
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Figure 32. Pseudo-colored FE-SEM micrographs of differentiated MNs (in purple) for 14 
days on various substrates. Dotted arrows indicate the direction of 3DG alignments.  
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4.3.1.3. Characterization of differentiated MNs and DA neurons 
For verifying the identities and maturity levels of the differentiated subtype neurons, 
both immunofluorescent imaging and qRT-PCR analysis were evaluated.  
After 6 days of differentiation, graphene substrates demonstrated more adhered 
Tuj1+/HB9+ mature MNs compared to control (Figure 33). Enhanced cell attachment was also 
well noted from the 3D-rendered video when MN aggregates were formed along the 
microgrooves of the patterned 3DG (Figure 34). Although both sheet and 3DG substrates are 
electroactive, much fewer cells were attached on the sheet (Figure 34A) compared to 3DG 
(Figure 34B). From the magnified image of the neural aggregates, it was observed that more 
adhesive contacts with neighboring cells were formed from the NSCs differentiated on 3DG 
(Figure 34C). As demonstrated from the SEM micrographs (Figure 32), extended neurite 
projections with the formation of axon-like features were identified in Figure 34D. It is not 
well known how cell density and substrate-mediated cell-cell interactions (contact cues from 
neighboring cells) instruct NSCs to mature neural subtypes, but it would be worthy of further 
investigation in the future. This would help to optimize the seeding density of the 
differentiation protocol for tailoring to the specific neuronal cell fate.  
For immunofluorescent studies, MNs were matured up to 14 days to evaluate the effect 
of substrate-mediated physical cues on the cell fate conversion. As shown from Figure 35, 
compared to glass control, 0.4- and 1.9-fold more NKX6.1+ cells, 2.8- and 9.5-fold more HB9+ 
cells, and 3.6- and 10.2-fold more ChAT+ cells were identified on sheet and 3DG, respectively. 
Based on the upregulation of these three somatic motor neuronal markers, 3DG exhibited a 
significantly more effective generation of mature MNs compared to that of the sheet.  
Similarly, the 14-day of differentiated MNs cultured on highly conductive platforms 
were compared to their donor cells for verifying their gene expression signatures. All 
expression levels of MAP2, Olig2, NKX6.1, ISL-1, HB9, and ChAT markers were   










Figure 33. 3DG substrate supports cell adhesion and MN maturation. Scale bar indicates 
100 μm. *Arrows indicate the direction of 3DG alignments 
Figure 34. 3D-rendered images for the differentiated MNs cultured on graphene-based 
composites. Differentiated MN cultured on graphene sheet (A), and aligned 3DG (B) for 6 days. 
Englarged motor neuronal network on 3DG (C) and aligned neuronal network across the aligned 
3DG (D). Dotted arrows indicate the alignment of the substrate 





Figure 35. The relative gene expression level of differentiated MNs for 14 days compared to 
the control substrate (glass).  
 
 
Figure 36. The relative gene expression level of differentiated MNs for 14 days compared 
to the original cell in log scale. Abbreviations: OLIG2, oligodendrocyte transcription factor 
2; NKX6-1, NK6 homeobox 1; ISL1, ISL LIM homeobox 1; HB9, homeobox HB9; CHAT, 
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significantly upregulated in 3DG compared to the sheet (Figure 36). From this data, it can be 
speculated that the patterned substrate elevated the expression of both early and mature markers 
of MNs, thereby activating the MN program and increasing the differentiation efficiency. 
Moreover, the results suggested a greater influence of micropattern-mediated physical cues on 
the maturation of MNs compared to culturing the cells on a highly conductive substrate (sheet).   
Similarly, the effect of substrate-mediated biophysical cues was examined for the 
directed differentiation of NPCs to DA neurons. While they naturally exist as 3D spheres in 
their niche environment, to investigate the feasibility of using the electroactive culture platform 
instead of the traditional platform, Kriks’ protocol was adapted (Kriks et al., 2011). After 
confirming the morphology change by adding the biochemical factors (Figure 31B), 11-day 
differentiated DA neurons were characterized with their mature marker, tyrosine hydroxylase 
(TH) and mature neuronal marker MAP2 (Figure 37). Unlike the alignment of MN aggregates 
along the microgrooves of 3DG, DA neurons did not seem to get influenced by the 
microgroove-mediated physical cues. As shown in Figure 37, the white dotted arrow indicates 
the direction of the microgrooves. Rather than forming structured neurites along the arrow, DA 
neurons formed a web-like structure with the neighboring cells throughout the 3DG substrate, 
which resembled the sophisticated connectivity and neurite extension patterns from the other 
substrates (control and sheet). However, TH+ DA neurons were only observed on the 
electroactive substrates (Figure 37). Moreover, compared to cells cultured on the TCPS control, 
18-day differentiated mDA neurons cultured on graphene:PLG composites possessed the 
genetic profile (both expressing early and late markers of mDA neurons) of mDA neurons 
(Figure 38). Similar to the results from the MN differentiation, for DA neuron differentiation, 
3DG significantly reinforced the cell fate conversion of NPCs to mDA neurons compared to 
the sheet by 3.75-fold.  
  


















Figure 38. Relative gene expression level of differentiated DA neurons for 18 days of 
expression level compared to the control substrate in log scale. Abbreviations: NURR1, 






















































Figure 37. Mature marker expression of differentiated DA neurons for 11 days 
on various substrates. White dotted arrow indicated the alignment of the substrate. 
Scale bar indicates 100 μm for top two and 50 μm for bottom. 
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4.3.1.4. Verifying the signatures of the mature MNs and DA neurons 
The induction of target cell fate conversion was verified from the morphology change and the 
protein and gene expression of the mature MN and DA neuronal markers. In order to fully 
recapitulate the bona fide mature subtype neurons, in this chapter, it was attempted to verify 
the functionality of these cells.  
For mature MNs, they were either co-cultured with the C2C12, an immortalized murine 
myoblast, or the primary mouse astrocytes to mimic their niche environments and maintain the 
stability of the cells to quantify their electrical excitability. However, due to the vigorous 
beating of the mature C2C12 myofibers upon seeding the mature MNs, muscle fibers were torn 
apart and it was not feasible to continue the functional evaluation of MNs (data not shown). 
While, for co-culturing with the primary murine astrocytes, due to the secure attachment of 
MNs on the graphene-based substrates, it was challenging to isolate MNs from the graphene 
substrates and culture them till the point of analysis. Therefore, only the cells co-cultured with 
astrocytes on the control substrate survived the additional two weeks of differentiation and 
evaluated for its functionality, including the patterns of action potential (AP) spikes, membrane 
properties, and other AP characteristic measurements (Figure 39, Figure 40, and Figure 41, and 
Table 5). A total of 42% of the selected mature motor neurons fired multiple AP spikes as 
shown in Figure 39, but the rest of other immature neurons fired few AP or aborted AP spikes. 
Along with the AP spikes, the average resting membrane potential (RMP) was measured as -
38.3 mV, where mature neurons typically indicate RMP of -60 mV. Overall, these results 
collectively represented that our directed differentiated protocol to MNs was not efficient.  
 For DA neurons, both the intracellular and extracellular DA concentrations were 
measured and normalized to the DNA content calculated from the mature DA neurons (Figure 
42). The results demonstrated that 3DG platform significantly elevated both the intracellular   










Figure 39. Different patterns of AP spikes recorded from the iPSC-derived MNs, directly 
differentiated for an extended period. Recordings are in the order of aborted AP signal, single 
AP spike, and functional MNs firing multiple AP spikes where y-axis is 10 mV and x-axis is 
during 200 ms.   
 
 
Figure 40. A box and whisker plots of the passive membrane properties of the differentiated 
MNs in the order of membrane resistance (mOhm), RMP (mV), and the capacitance across 
voltage (pF).  
 
 
Figure 41. A box and whisker plots of the AP characteristics of the differentiated MNs in the 
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Table 5. Summary of the quantified electrophysiology results from the iPSC-derived MNs  
Measurement Mean Standard error n 
Capacitance (pF) 22.68 1.82 11 
Membrane resistance (MOhm) 3467.84 533.29 12 
RMP (mV) -38.33 1.88 12 
Max number of APs 1.75 0.91 12 
AP duration (ms) 3.52 0.55 6 
AP threshold (mV) -29.02 2.58 7 















































Figure 42. Normalized HPLC analysis results for measuring the intracellular and 
extracellular dopamine release from the mature DA neurons after 35 days of differentiation. 
Total DNA content was measured by the Picogreen Assay. ** indicates p < 0.01 and * 
indicates p < 0.05  
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and extracellular concentration of DA from DA neurons after 35 days of long-term 
differentiation.  
Compared to the sheet, 3DG had an approximately 2-fold increase in both intracellular 
and extracellular DA concentrations. Therefore, more neuronal connectivity expressing TH+ 
DA neurons attributed to the higher maturity and functionality of the DA neurons. How the 
higher cell attachments on the aligned microgrooved patterns of the 3DG directly contributed 
to the improvement of functionality was not systemically assessed in this study. However, it 
would be interesting to further investigate in the future.  
Instead of pursuing other options to verify the correlation between the cell seeding 
density and its cell fate conversion efficiency, a pilot study was conducted to visualize the 
mature MNs on the graphene substrates using the pLV-hSyn-RFP lentiviral plasmid. Cells 
infected with the lentivirus bearing the plasmid expressed RFP upon the expression of human 
synapsin (Figure 43). Protamine sulfate (PS) was added at a lower dosage over a range of MOIs 
in order to increase the efficiency of lentiviral infection. Based on the increasing MOI dosage, 
the RFP expression significantly increased proportionally, quantified by the expression of 
DsRed from the qRT-PCR (Figure 44). However, similarly, as the mature MNs were unable to 
be fully detached from the substrate, the majority of the RFP expressing MNs were still 
attached to the substrate after the detachment procedure. For further assessment of the cell 
functionality, a more optimized detachment procedure should be established to pursue the 
patch-clamp study on the cells cultured on graphene-based substrates.  
 
  






Figure 43. Lentiviral titer test for infecting NSCs with lentiviral encoding hSyn-RFP with and 























































Figure 44. Quantification of the dose-responded RFP gene expression as the MOI increased. 
**** indicates p < 0.001. 
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4.3.2. Transdifferentiation of chemically-induced neurons  
In addition to promoting the differentiation of the NS/PCs to target neuronal subtypes, in the 
second half of the project, we investigated if this highly electroactive substrate can also enhance 
direct conversion of fibroblasts to chemically-induced neurons. Small molecule mediated 
direct reprogramming is more advantageous over traditional lineage conversion procedures 
involving delivery of TFs because of the following advantages: 1) they are stable, cell-
permeable, and easy to prepare; 2) they are safe as they obviate the need of using virus as a 
delivery vehicle; 3) they allow simple, rapid, and cost-effective method to epigenetically 
convert the cell fate; and 4) they allow the cell phenotype to be finely tuned by modulating 
their concentrations and lengths of exposure to donor cells. For our study, 8 chemical cocktails 
were exposed to fHDF-GFP at different time points to promote its conversion to neuronal 
lineage (Figure 45). Neural induction media promotes the neuronal conversion of fibroblasts 
and maturation media promotes survival and maturation of induced neurons.  
Over 20 days, changes in cell morphology and neurite elongations implied that 3DG 
promoted the adhesion and aligned growth of chemically-induced iNs along the micropatterns 
compared to the control and the sheet substrates (Figure 46A). The neurite orientation of the 
cells was quantified based on the preferred spatial orientation of cells represented as an angle 
measured from the positive y-axis position, where 0° indicated the horizontal axis (Figure 
46B). As shown in Figure 46C, the iNs from control and the sheet spread out randomly in 
multiple directions with directionality ranging from -181 to 73°, while the iNs on the 3DG had 
less than 10° dispersions in their preferred growth orientation throughout the differentiation 
process. Such results suggested that iNs on 3DG preferred aligning and extending along the 
microgrooved patterns.  
In order to confirm the pan-neuronal marker of the transdifferentiated iNs, cells were 
stained with Tuj1 and quantified for their neurite lengths (Figure 47). In the early phase of 
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lineage conversion, it was interesting to note the distinctive mixtures of heterogeneous cell 
populations; the green-colored fhDF-GFP, which did not fully transdifferentiated into iNs, and 
the red-colored Tuj1+ cells, including both chemically induced immature and mature neurons. 
After the neural induction stage, due to the chemical cocktails inducing the neural maturation, 
more populations of Tuj1+ iNs were observed over the GFP+ populations (Figure 47A).  
ICC data also suggested that the iNs from the 3DG had longer total neurite lengths 
compared to other substrates at Day 16 and the average neurite length per cell was significantly 
enhanced at the early stage of induction on 3DG (Figure 47B). During the neural induction, all 
the substrates well supported the lineage conversions of fhDF-GFP. However, during the neural 
maturation period, the addition of MM triggered more cell deaths, which implied the lack of 
mature iNs on the other substrates compared to 3DG. Besides, the discrepancy over the cell 
seeding density might have caused by the increase in passage number of the primary fhDF-
GFP. Such an uncontrollable parameter affected the cell behaviors significantly, although only 
the passage number below 10 was used for the study.  
Collectively, the results of specific aim 2 implied that 3DG might serve as a potential 
platform for neural cell cultures. Interestingly, graphene with the aligned micropatterns (3DG) 
had a more significant effect on guiding cells to neuronal phenotypes compared to having 
graphene sheets. However, to make a conclusive summary, more tests need to be conducted to 























Figure 45. Chemical factor-induced lineage conversion schedule for generating iNs from 
fHDF-GFP. 
Figure 46. Epigenetically-reprogrammed iNs using chemical cocktails. Change in cell 
morphology (A), how the directionality angle was measured (B), and the resulting directionality 
(C) of iNs over time for each substrate (n = 3-4). Scale bar indicates 200 (top; for 10X) and 600 
µm (bottom; for 4X).  
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Day 16 Day 8Day 4
Figure 47. Small molecule-mediated direct lineage conversion of fhDF-
GFP to iNs. Pan-neuronal marker expression from iNs across various 
substrates (A) and the total neurite length and average neurite length per cell 
(B). Scale bar indicates 200 µm. * indicates p < 0.05.  
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5.1. Summarized Conclusion  
Programming one cell fate to another target cell lineage provides tremendous opportunities for 
utilizing these therapeutic cells, 1) directly as potential sources for cell-based therapy to treat 
inoperable diseases in the neuronal and muscular systems, or 2) indirectly to recapitulate the 
dynamic neuronal and muscular programs for developing drugs for specific diseases. Both 
applications are exciting enough for both researchers and patients as either application can lead 
to optimal personalized medicine if patients’ cells could be used as a cell source. In this aspect, 
in Chapter 3. In situ reprogramming of EPCs by transactivation of endogenous MYOD1 using 
the CRISPR/dCas9 system and Chapter 4. Enhancing the neural cell fate commitment by 
deploying biochemical cues and substrate-mediated electrophysical cues, we attempted to 
guide the origin cell fate of both stem/progenitor and somatic cells into iSkMs, MNs, DA 
neurons, and iNs by mimicking their niche in the neuronal and muscular systems. From both 
aims, we learned the combinations of intrinsic and extrinsic signals lower the epigenetic 
barriers to promote the myogenic and neuronal cell fate conversions.  
 
5.1.1. Conclusion for Chapter 3 
In Chapter 3. In situ reprogramming of EPCs by transactivation of endogenous MYOD1 using 
the CRISPR/dCas9 system, we first demonstrated utilizing the CRISPR/dCas9-mediated 
targeted transcriptional system to instruct EPC fate to committed iSkM in situ. As we 
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hypothesized, only by inducing transdifferentiation of EPCs (with the administration of dox), 
resulting iSkM integrated to the host tissue, promoted 2-fold elevated level in local 
angiogenesis, and reduced 50% of skeletal muscle fibrosis. Hence, collectively accelerating 
muscle regeneration process and preventing further myotoxin-induced muscle damage leading 
to fibrotic tissue and  impairment in muscle function. Unfortunately, we could only speculate 
the maturation and functionality of iSkM from this combined therapeutic effect in vivo, which 
was significantly beneficial compared to other negative controls, as summarized in Table 3.  
Employing the catalytically-deficient dCas9 system, dual fused with VP64 activation 
domains (VdC9BV), yielded a direct lineage conversion which offers economical, simple, safe, 
rapid, and accessible means to obtain autologous iSkMs while avoiding the use of iPSCs. 
Additionally, local delivery of reprogrammable cells obviates the need to directly inject the 
dCas9/gRNA elements for the in vivo reprogramming, thus precluding the off-targeting 
concerns associated with the CRISPR/Cas9 technology. Furthermore, this versatile tool offers 
multitudes of benefits for driving cell fate commitment: 1) it enables robust and efficient 
transcriptional activation of the endogenous gene(s) with an option to multiplex; and 2) unlike 
traditional transcription factor delivery, it allows activation of large-sized targets by recruiting 
gRNAs to the multiple target loci. 
Collectively, demonstration of our work on CRISPR/dCas9-mediated in situ cell fate 
conversion bestows new source for autologous cell-based therapy in a pathophysiologically-
relevant injury model in a postnatal mammalian tissue. As a proof-of-concept, this technique 
also offers possible means to utilize CRISPR/dCas9-based cell therapy for ameliorating other 
human injury or disease symptoms or understanding one’s stem cell niche to ultimately aid in 
preclinical testing for new drug discovery and screening myotoxins for personalized medicine. 
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5.1.2. Conclusion for Chapter 4 
It has been well documented that insoluble factors (including surface compositions, rigidity, 
and topology, or by delivering soluble transcription factors), which mimics the niche of the 
target organs, can regulate cellular behaviors and direct the cell fate towards the desired 
lineages. The detailed mechanisms of their effects on transforming cell behaviors, including 
proliferation, differentiation, and transdifferentiation, are not fully elucidated for all cell types. 
However, the spatiotemporal cues experienced by the cells resulted in facilitating 
reprogramming and transdifferentiation processes by committing to new cell identity.  
  In Chapter 4. Enhancing the neural cell fate commitment by deploying biochemical 
cues and substrate-mediated electrophysical cues, three different cell types were tested to 
explore how their cell fate decisions are affected by their exposed microenvironments. The 
specific biophysical cues of our interest were the unique surface characteristics offered by 
graphene:PLG composites, including the endogenous bioelectrical cue and the topographical 
cues from the microgrooved patterns in 3DG. Combined with the soluble and insoluble cues 
from the coated ECM proteins and the biochemical factors supplied from the media, we 
proposed that the efficiency of directed differentiation to sub-neuronal types (MN and DA 
neurons) and that of transdifferentiation to iNs would be enhanced on the graphene-based 
substrates.  
As highlighted from our results, the physical properties of 3DG along with the soluble 
cues facilitated the directed differentiation and transdifferentiation of donor cells to target 
neuronal subtypes. On 3DG, the matured MN cells expressing HB9+ and ChAT+ increased by 
10-fold, while for the graphene sheet, the mature MN population increased by 3-fold compared 
to the control (glass) substrate. Similarly, for the mature TH+ DA neurons, 3DG promoted the 
maturation of DA neurons by 1.5-fold, whereas on the graphene sheet, TH+ expression 
increased by 0.4-fold compared to that of control. Electroactive substrates also extended the 
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neurite lengths of chemically-iNs, directly converted from fhDF-GFP. On day 15, 3DG 
facilitated to extend the neurite length by 7.5-fold, whereas, on a sheet, it was elongated by 
1.5-fold. Unlike other neuronal cell types, the excitable pan-neurons preferred to elongate 
along the microgrooves of 3DG, as suggested by the quantified spatial directionality of the 
neurites. 
Among all the target neuronal cells, DA neurons had the least effect on the substrate-
medicated physical cues as no structured cell aggregates like MNs or neurite extension like iNs 
were observed along the microgrooves. Therefore, the 3DG platform may be more suitable for 
the differentiation of MNs and transdifferentiation of the chemically-iNs.  
Collectively from our results, it can be implied that substrate-mediated biophysical and 
electrical cues, when coupled with biochemical stimuli, could offer a more permissive 
microenvironment to drive neural subtype specifications and transdifferentiation. Such cell fate 
transitions were promoted by enhancing the donor cell behaviors to adhere, spatially align, 
differentiate, and mature to target neuronal subtypes. Therefore, culturing donor cells in 
chemically-defined conditions on conductive graphene-based substrates with aligned patterns 
enable accessible means for improving the current differentiation protocol using the traditional 
tissue culture plate or glass substrate. By facilitating the cell fate conversion to a higher number 
of target neuronal subtypes for extended periods of in vitro culture, this electroactive in vitro 
culturing platform can be potentially utilized for regulating NS/PC fate and behaviors and for 
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5.2. Future Perspectives 
 
5.2.1. Future perspectives on increasing the clinical adaptability of 
CRISPR/dCas9 tool 
For increasing the clinical utility of the CRISPR/dCas9, further efforts can be made to deliver 
smaller-sized cas9 variants and gRNAs in a polycistronic vector. In our approach, SpCas9 was 
utilized as the usage of ‘NGG,’ PAM sequence is commonly expressed in human cells. 
However, the cDNA for SpCas9 is estimated to be 4.1 kb long, which translates into 1368 
amino acids (Jinek et al., 2012). As an alternative option, Staphylococcus aureus (SaCas9), 
which is 1000 bp smaller than SpCas9, can be utilized (Gee, Xu, & Hotta, 2017). Besides, 
reducing the size of Cas9 protein, gRNAs can be delivered more efficiently via a polycistronic 
vector, encoding multiple gRNAs by harnessing the natural tRNA-processing system for co-
delivery of all gRNA elements in one vector (Xie, Minkenberg, & Yang, 2015). This eliminates 
the need to deliver redundant viral plasmid backbones to increase delivery efficiency. The 
polycistronic tRNA-gRNA (PTG) gene encodes for multiple tRNA-gRNAs under the 
polymerase III-promoter. Then, the endogenous tRNA-processing RNases get recruited and 
cut the gRNAs out from the PTG transcript, resulting in the recruitment of multiple gRNAs to 
the target loci. This technique would be particularly beneficial in clinical applications as the 
adeno-associated virus may be used as a safer option than lentivirus. 
With the advances in epigenetic engineering, fusing these effector domains to 
CRISPR/dCas9 allows durable manipulation of multiple genes more efficiently without 
causing risky genetic mutations, associated with gene-editing. Molecules targeted for 
epigenetic manipulations involve DNA methylation, histone methylation, and acetylation. For 
instance, fusing dCas9 with the human acetyltransferase domain, p300 allows sufficient 
activation of a target gene from both promoter and the enhancer regions by catalyzing the 
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targeted lysine 27 region of histone 3. Moreover, activation efficiency increases by de-
condensing the chromatin structure for endogenous activation to occur in a more permissive 
environment for cell fate change. For the application of targeting neurodegenerative diseases 
or the brain injury, Geminin, a cell cycle regulator, can be fused to Cas9 for reducing the 
neurotoxicity in the brain by eliminating remaining Cas9 constructs after gene-editing (Yang, 
Li, & Li, 2018). Hence, with a reduction in size, increased in efficacy, and having safer AAV 
delivery options, targeted gene activation mediated by CRISPR/dCas9 can extend its clinical 
utility to achieve autologous-cell therapy or in vivo gene therapy for multiple human 
diseases/disorders with ease in multiplexing.  
 
5.2.2. Future works proposed for Chapter 4 
For neuronal cells obtained from Chapter 4. Enhancing the neural cell fate commitment by 
deploying biochemical cues and substrate-mediated electrophysical cues, we collectively 
exploited the microenvironmental cues mimicking the niche-like environs to guide stem cell 
fates to neurons. To better recapitulate the bona fide functional neurons in vitro, the 
investigation will proceed to confirm the functionality of MNs and iNs via conducting the 
whole-cell patch-clamp.  This would validate the developed pre-synaptic and post-synaptic 
structures and ion channels for mature neurons. Two different options are proposed for 
analysis: 1) detaching the cells from graphene substrate to co-culture with mouse astrocyte 
feeder layer to support their growth after detachment, or 2) visualizing the cells directly on the 
graphene substrate by transducing the cells with pLV-hSyn-RFP; this plasmid allows the 
expression of RFP upon human synapsin activation. The second option would leave the 
intricate neurite formed by mature DA neurons, thereby potentially receiving higher 
populations cells with firing action potentials. However, graphene being not transparent, this 
option would require an inverted microscope to proceed. 
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After confirming the functionality of MNs, obtained cells can further extend its usage 
in vitro and in vivo applications for tissue engineering and regenerative medicine applications 
against neuronal diseases. It would be necessary to elucidate the molecular mechanisms of 
electroactive substrates on cell-to-matrix or cell-to-cell signal transduction. This would allow 
us to tailor the cell fate to the cell-specific platform, intricately designed for maximizing its 
clinical efficacy or mimicking its native behavior in vitro. Furthermore, knowing the specific 
cues to direct the cell fate to target cells offers exciting opportunities to realize personalized 
regenerative cell-based therapy by small molecules and conductive substrates, instead of 
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